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This research argues that the rise of alternative medicine and health supplements is best 
understood within the context of the ‘risk society’. The dual pressures of deregulation in the 
health sector of the economy and the dominance of Big Pharma, has the consequences of 
proliferating the use of non-sanctioned forms of health care. The Southeast Asian plant Kratom 
is one such illustration of this phenomenon. Drawing from over 200 Reddit posts on r/Kratom, 
this research analyzes the reaction of the kratom community to attempts by the Food and Drug 
Administration and Drug Enforcement Administration to restrict access to the botanical. Ulrich 
Beck’s work on ‘risk society’ is combined with the recent literature on neoliberalism to analyze 
the narratives emerging from the community of kratom users. Using theme-based coding, the 
findings revealed tent-pole sentiments of 1) A desire for treatment agency and personal liberty, 
2) Fear of regression or return to risk, and 3) Disdain and distrust of regulatory agencies and the 
pharmaceutical industry. Parallels to Beck’s risk society were extant in the thematically related 
passages, including 1) the commonality of anxiety, 2) crises of trust and the loss of monopoly on 
knowledge from authoritative institutions, 3) the transition from patient ignorance versus being 
their own auxiliary doctor in the modern era, and 4) the power of corporatocracy overshadowing 
the traditional preeminence of the state. These arguments indicate a more nuanced understanding 
of neoliberalism is required. While typically seen as a way of freeing up capitalist markets for 
the benefit of large corporations such as Big Pharma, neoliberalism’s emphasis on self-reliance 
and entrepreneurialism also provides a frame of resistance for those non-corporate actors 
 
 
threatened by State regulation. These findings enhance our understanding of the role of States 
and sub-community resistance in Ulrich Beck’s theory of ‘risk society’. In the context of risk 
society, the kratom community’s experience with mainstream medicine and subsequently the 
pharmaceutical industry has made them distrusting of the state due to its failings to properly 
police such institutions and would rather be left to their own devices to decide what is and isn’t 
appropriate for their respective conditions. 
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The origins of the risk society are explored and discussed as it pertains to the FDA, 
pharmaceutical industry, and the neoliberal political ideology that has steered the United States 
in its modern history. I analyzed the top 200 most replied-to posts made to the Reddit page 
r/Kratom from a nearly two-month period, 08/30/16 to 10/29/16. The start date marks the day on 
which the DEA first announced its intent to schedule kratom and end date is 17 days after it was 
announced that they would no longer go forward with the ban. Primary themes that arose are 
illustrated. 
The statements made by kratom subreddit members are connected to risk society through 
themes related to individual liberty, antipathy for government intervention, and assumptions of 
government corruption.  This analysis and discussion showed a strong relation to the impact that 
neoliberalism has had on shaping modern medicine in the United States.  Particular attention was 
paid to the relationship between government, the powerful pharmaceutical industry, and dietary 
supplements such as kratom. Interestingly, central tenets of neoliberalism such as free markets, 
deregulation, personal liberty and responsibility have allowed alternative medicines such as 
kratom to flourish alongside “Big Pharma”.  What happens however, when pressure is placed on 
the government to step in and regulate substances like kratom on behalf of pharmaceuticals?  
This research attempts to capture some of the social dynamics that arise in just such a situation.  
Since its inception with the 1994 Dietary Supplement and Health Education Act the 
dietary supplement market has grown to be a booming industry, with its global market projected 
to be worth $230 billion by 2027 (Grand View Research, 2020). Its largest market is currently 
North America (Grand View Research, 2020), which comes as little surprise given that an 
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estimated 86% of American adults take some form of vitamin or supplement (American 
Osteopathic Association, 2019). Amongst the massive pharmacopeia of products available is one 
that is exceptionally contentious amongst its proponents and regulatory agencies—kratom. 
Prized for its pain-killing and mood-elevating properties, kratom has been hailed by many as 
being an ideal safer and natural alternative to prescription painkillers. In 2016 the DEA 
announced it would ban kratom as a Schedule I substance, a category reserved for drugs of high 
addiction potential and no medicinal value. This sparked outrage in the kratom user community 
that transformed into a grassroots political movement determined to thwart the Drug 
Enforcement Administration’s efforts.  
I am actively involved with following the supplement market and am always interested in 
what the hot new product is. Kratom inevitably fell into my purview and I eventually came 
across the Reddit forum dedicated to discussions surrounding the botanical. During this time I 
witnessed a growing fervor as news of the DEA’s intentions broke out onto the site. What ensued 
was a powder keg of sociopolitical discourse and grassroots organizing that was enthralling to 
witness, especially given the outcome.   
This area of study should be of interest to sociologists because it speaks to a prominent 
shift in how Americans view health, wellness, and their developing responses to the current 
mainstream methods of healthcare and facets of the healthcare system. The nature of these 
responses and the circumstances preceding them fit into Ulrich Beck’s Risk Society concept. 
Exploration of neoliberalism and risk society is a natural pairing, as it was the advent of 
neoliberalism to Western democracies in the 80s that catalyzed the development of risk society 
by the way in which it facilitated a shift from an industry-driven economy to that of a 
technology, information, and finance-driven economy, and served to diminish the State’s role in 
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day-to-day life. State authority was then subverted to accommodate the demands of these new 
realms of the economy. Reddit’s relation to this pairing stems from the statements and actions 
made by the users who posted to r/Kratom tracking neatly with them. They showed an awareness 
of the government’s acquiescence to the pharmaceutical industry’s demands, held great antipathy 
towards government oversight into their personal lives, and expressed anxieties about the 
impending ban that spurned them into action that facilitated change, all while acting and 
organizing outside of the political sphere; these features interplay between the predominance of 
neoliberalism and the traits of risk society. Thus my research question became: in a risk society, 
what narratives of resistance emerge pertaining to healthcare? 
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II. LITERATURE REVIEW 
Virtually no research exists regarding kratom’s legal battles and the conflict between its 
proponents and regulatory bodies. Aside from Nichter and Thompson’s research on dietary 
supplement users, most relevant literature is centered around adjacent topics such as the history 
and pharmacology of kratom, the origins and structure of the dietary supplement market, the 
developmental history of the pharmaceutical industry, and the history of the FDA and how its 
relationship with the pharmaceutical industry has changed over the past several decades. 
Overhanging these subjects is the historical backdrop for and inception of neoliberalism in 
America. 
KRATOM’S ORIGINS AND PHARMACOLOGY 
Kratom (mitragynine speciosa) is a tree native to Southeast Asia, including Thailand, 
Malaysia, Borneo, and Indonesia. It belongs to the Rubiaceae family, sharing relation to both the 
gardenia and coffee plant (Cinosi et al. 2015). Use of the tree’s leaves has been documented in 
the region for hundreds of years, utilized medicinally as a cough suppressant, painkiller, 
antidiarrheal, and for treating opium dependency (Grinspoon, 2019). It is also commonly used by 
day laborers in the region for its energy-producing effects and is traditionally consumed by 
chewing the whole leaf or by steeping it into a tea, though in the west the leaves are usually 
ground into powder and then mixed into a drink or put into capsules to avoid its rather bitter, 
earthy taste. 
In recent years it has grown in popularity in the United States, where it has been sold as a 
dietary supplement. Here it is touted by its adherents as being beneficial for chronic pain, mood 
disorders such as anxiety, depression and PTSD as well as a means of curbing addictions and 
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dependencies to other substances such as alcohol, marijuana, prescription opioids and their illicit 
counterparts.  
As the plant’s popularity has grown, so has its legal troubles. A rise in reported 
hospitalizations and deaths attributed to kratom use has drawn the attention of the Drug 
Enforcement Agency, Food and Drug Administration and numerous state legislatures, all of 
whom have made attempts to ban the sale of kratom in some capacity at their respective levels of 
government. From the perspective of the State, kratom is a recreational drug with no medical 
value and has deadly risks associated with its use. In contrast, the community of kratom users 
claim that kratom has brought real positive change to their lives. Additionally, kratom is seen to 
be a treatment that is devoid of the myriad side effects associated with standard pharmaceuticals. 
Many of its proponents accuse government agencies of doing the bidding of Big Pharma by 
misconstruing the data about kratom to justify their interest in outlawing the plant and 
substituting its use with a patented, synthetic alternative (Roberts, 2019).  
The implications of kratom’s use in the United States has only recently fallen under the 
purview of the scientific community. This preliminary analysis has revealed that the claims made 
on each side of the “kratom debate” cannot be so easily written off as unequivocally true or 
patently false. In fact, the fervent debate surrounding kratom occurs over even most elemental 
traits of the botanical. Specifically, the issue pivots on whether it should be classified as an 
opioid or not. While kratom’s predominant alkaloids, mitragynine and 7-hydroxymitragynine do 
appear to interact with mu-opioid receptors much like conventional opiates and opioids do, they 
(or possibly one of the other 37 alkaloids identified in kratom) also appear to have activity in the 
brain’s adrenergic (related to adrenal function and the production of epinephrine and 
norepinephrine) and serotonergic (serotonin-related) systems (Singh et al. 2019). Though not 
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fully understood, it is theorized that kratom’s activity in these systems could account for the 
mood-elevating and stimulating effects reported by users (Prozialeck et al. 2019). 
It has also been demonstrated that kratom does not produce respiratory depression to the 
degree seen with other opioids, ostensibly making it less risky in this regard compared to 
conventional opioids (Váradi et al. 2016). The reasoning offered for this novel mechanism stems 
from the theory that activation of the mu-opioid receptors prompts the release of a protein called 
beta arrestin, which after a certain level of concentration begins a cascade of effects that 
ultimately interfere with the functioning of the diaphragm, thus causing respiratory depression 
(Arnst, 2017). While a substance like morphine fully activates the mu-opioid receptors, kratom is 
only a partial-agonist, meaning that it does not elicit a full-spectrum response from the receptor 
site. The unique and diverse range of kratom’s pharmacological profile has led it to provisionally 
be described as an ‘atypical opioid’ and may represent a unique class of drugs (Prozialeck et al. 
2019).  
The overall alkaloid profile of any given plant seems to determine the degree of balance 
between the plant’s effects, with some batches of kratom exhibiting more sedating and 
painkilling effects and others more stimulating and mood-elevating. These in turn are thought in 
part to be dictated by the age of the tree: the older the tree, the more potent the leaves will be. 
The differences in alkaloid content have been categorized into ‘vein’ types, referring to the 
coloration of the leaves’ veins as an indicator of its primary effects. The main categories are 
green, red, and white-veined kratom (Kratom Science, 2019). Red-veined kratom is associated 
with more anti-anxiety, painkilling and sedating effects while white is more stimulating and 
euphoric, with green veins sharing characteristics of both (Kratom Science, 2019). Additional 
classifications of yellow and gold exist and are achieved through allowing the leaves to dry and 
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age for a longer period of time, thereby altering the alkaloid profile. The effects of yellow and 
gold strains are described as a combination of reds and greens. 
On top of these distinctions, kratom is assigned different names to further signify the 
orientation of the plant’s effects, such as Thai, Malay, Indo, and Bali. For example, Bali strains 
are thought to be more on the relaxing side, so Red Bali kratom is highly touted for powerful 
painkilling and sedating effects (Kratom Science, 2019). There are no rules in place regarding 
what the kratom is named versus what its appearance and alkaloid profile are, nor standards set 
for alkaloid content, so branding is not an inherently reliable indicator of how it will affect a 
person. The names used also seem to imply that they are representative of that plant’s country of 
origin but this is unlikely, as it is estimated that 95% of the world’s kratom imports are harvested 
and shipped from Indonesia (Hess, 2019).   
People also report differences in effects as being dose-dependent, with smaller dosages 
leaning more towards stimulation and euphoria and larger ones more painkilling and sedating. A 
study by Sing et al. measured the reported stimulant and sedative effects of kratom with both 
new and long-term daily users and did not find any significant differences in reported effects 
between smaller and larger doses other than larger amounts proportionally increasing the 
intensity of both (2019), so this guideline appears contentious. 
While kratom is not as potent as synthetic opioids and does not seem to carry the same 
severity of risks, this is not to say that kratom is harmless. Side effects such as nausea, reduced 
sex drive, dehydration, constipation, and dizziness have been reported, and dependence is 
possible with habitual use. The possible withdrawal symptoms are like those seen from 
conventional opioids: diarrhea, sweating, cold or flu-like symptoms, trouble sleeping, restless 
legs, depression, anxiety, irritability, and fatigue. The severity of such symptoms is described to 
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be on the milder side when compared to conventional opioids but is also dependent upon 
duration of use and level of consumption, as well as individual body chemistry. The overall 
effects of long-term habitual kratom use are largely unknown. One study of Malaysian users 
mentions, “Long-term addicts are described to become thin and have skin pigmentation on their 
cheeks, due to the capacity of mitragynine to increase the production of melanocytes-stimulating 
substance” (Cinosi et al. 2015). Aside from this small piece of information, long-term effects are 
still largely unknown and understudied.  
NEOLIBERALISM AND THE SOCIOPOLITICAL PRECEDENT FOR THE DIETARY SUPPLEMENT 
MARKET 
Kratom provides an ideal window into the sociopolitical machinations that surround 
access to alternative health products, especially given that this market has arisen in the 
dominating shadow of Big Pharma. One major element that led to such a situation is 
neoliberalism. This ideology of political thought and policy was first birthed in mid-20th century 
Europe and matured into the more radical form it is recognized as today when it reached the 
USA several years later (Stedman Jones, 2013). Before it became actively employed in policy 
decisions and subsequently became a cultural ethos, it was merely a concept that was planted in 
the sociopolitical climate of post-World War II in the hopes that it would take root and flourish 
under the right conditions. In the 1950s, economists such as Milton Friedman and Aaron Director 
from the Chicago School argued that monopolies were the result of the government favoring 
certain companies over others, and that corporate structures and incentive systems naturally 
encouraged competition. Adherents of what was to become known as neoliberalism also argued 
that labor unions had undue influence over the economy and were directly responsible for 
hampering the proper functioning of markets in a capitalist society (Jones 2013). Neoliberalism 
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was incubated in academia and appealed to corporations. Corporations then funded think-tanks 
to propagate its proposed merits, at which point parts of the media were swayed to cheerlead the 
concept further, which would lead to fostering a supportive climate for the movement to develop 
further. From there it was a matter of capturing political parties which would then beget state 
influence. As has been alluded to, this was made possible through the fertile ground of 
geopolitical, idealistic and economic circumstances. In his book A Brief History of 
Neoliberalism, David Harvey describes the postwar economic directives of democratic states 
prior to the introduction of neoliberalism: 
“. . .an acceptance that the state should focus on full employment, 
economic growth, and the welfare of its citizens, and that state power should be 
freely deployed, alongside of or, if necessary, intervening in or even substituting 
for market processes to achieve these ends. Fiscal and monetary policies usually 
dubbed ‘Keynesian’ were widely deployed to dampen business cycles and to 
ensure reasonably full employment. A ‘class compromise’ between capital and 
labour was generally advocated as the key guarantor of domestic peace and 
tranquility. States actively intervened in industrial policy and moved to set 
standards for the social wage by constructing a variety of welfare systems (health 
care, education, and the like)” (2007:10). 
 
The security of this economic directive would be imperiled by the fears of the economic 
elite in the face of growing socialist and communist movements in the 1960s. Neoliberalism 
began to be espoused as the silver bullet for vanquishing the threats to capitalism and the 
freedoms it granted. No other group carried this torch with greater fervor than the Mont Pelerin 
Society, a group consisting of academics and philosophers—including Milton Friedman. It was 
started by Austrian philosopher Friedrich von Hayek, who believed that neoliberalism must 
prevail in the war of ideas if the threat of communism was to be abated (Harvey, 2007).  
Neoliberalism stayed a mere idea until the 1970s. In the wake of deindustrialization, the 
oil crisis of 1973, and “stagflation”, support for the implementation of neoliberal policies grew. 
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Chairman of the Federal Reserve Paul Volcker was the first to set the change in motion by 
abandoning New Deal and Keynesian economic directives and implementing policy to drive 
down inflation—no matter the cost to the job market—which ultimately led to an economic 
recession (Harvey, 2007). Democratic president Jimmy Carter soon followed up with his own 
neoliberal implementations by deregulating the airline, transport and finance industries (Jones, 
2013).   
Though its grafting into American policy is historically marked in the late 1970s, 
neoliberalism became the lodestar for United States economic and social policies under President 
Ronald Reagan and has been so ever since. Neoliberalism’s guiding principles are that of laissez 
faire economics and deregulated markets with little government oversight or regulation 
interfering with the “natural processes” of the economy, save for certain circumstances. 
 “The role of the state is to create and preserve an institutional framework 
appropriate to such practices. The state has to guarantee, for example, the quality 
and integrity of money. It must also set up those military, defense, police, and 
legal structures and functions required to secure private property rights and to 
guarantee, by force if need be, the proper functioning of markets. Furthermore, if 
markets do not exist (in areas such as land, water, education, health care, social 
security, or environmental pollution) then they must be created, by state action if 
necessary” (Harvey,  2007:2).  
 
Included in this belief is the conviction that any social welfare programs the government 
offers could be better run and more effective by means of privatization, lending the reins of 
management to the free market. This last tenet is what drives the gutting of social welfare 
programs in public policy under the auspices of neoliberalism.  
The question of how such a socioeconomic ethos could gain popularity in the population 
outside of the economic elite is a matter of how it was packaged. An emphasis on personal 
freedom and liberty was the ticket, especially in the cultural climate of the 1980s. 
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“Neoliberalization required both politically and economically the construction of a neoliberal 
market-based populist culture of differentiated consumerism and individual libertarianism. As 
such it proved more than a little compatible with that cultural impulse called ‘postmodernism’ 
which had long been lurking in the wings but could now emerge full-blown as both a cultural 
and an intellectual dominant” (Harvey, 2007:42). Hitching the neoliberal wagon to these ways of 
thinking gave the impression that its existence was to the extreme benefit of any given 
individual, when the real goal was “. . . capturing ideals of individual freedom and turning them 
against the interventionist and regulatory practices of the state. . .” (Harvey, 2007:42). 
Fortune 500 companies began funding think-tanks to fabricate data that would extol the 
virtues of neoliberalism, which subsequently influenced universities and their economics 
departments. New campaign finance laws in 1971 opened the door for such companies to begin 
injecting inordinate amounts of money into the political system through political action 
committees to influence legislation to their benefit. The historically pro-business Republican 
Party was the first to be seized, with the Democratic Party following suit on account of having no 
single large constituency amongst its varied demographics of supporters with which they could 
count on bankrolling their operations. In his book A Brief History of Neoliberalism, David 
Harvey lays out in greater detail the circumstances that compromised the Democratic Party and 
allowed the Republican Party greater electoral strength: 
“The dependency of Democrats. . .on ‘big money’ contributions rendered 
many of them highly vulnerable to direct influence from business interests. While 
the Democratic Party had a popular base, it could not easily pursue an anti-
capitalist or anti-corporate political line without totally severing its connections 
with powerful financial interests. The Republican Party needed, however, a solid 
electoral base if it was to colonize power effectively. It was around this time that 
Republicans sought an alliance with the Christian right. . .It also appealed to the 
cultural nationalism of the white working classes and their besieged sense of 
moral righteousness (besieged because this class lived under conditions of chronic 
economic insecurity and felt excluded from many of the benefits that were being 
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distributed through affirmative action and other state programmes). . .The 
problem was not capitalism and the neoliberalization of culture, but the ‘liberals’ 
who had used excessive state power to provide for special groups (blacks, women, 
environmentalists, etc.) . . .” (2007:49-50). 
 
The most thinly veiled component of neoliberalism is that its economic policies serve the 
interests of both businesses and consumer alike. In reality, only one participant in this economic 
layout gains benefits, and it is not the consumer. Consumer protections get stripped away, 
allowing for more dubious methods of conducting business to go unhindered. Robert Kuttner 
(2019) argues that neoliberal policies are a way for the economic elites to cement their place in 
the upper echelons of power and to ensure that no one else may ascend to upend their position. 
Monopolized markets continue to emerge, as companies with enough power and influence 
develop a stranglehold on their respective markets that chokes out or diminishes any potential 
competition, with no meaningful regulatory laws left to keep such behavior in check. Kuttner 
also argues that the metastasizing of neoliberalism in American policy has become a threat not 
only to the health and stability of the markets, but democratic processes as well. Corporations are 
permitted to participate in the political process through lobbying and PACs with budgets the 
average citizen (or even hundreds or thousands of average citizens) could not hope to match. 
Such a free reign of influence ultimately rots the foundations of democracy and makes for a 
political and economic environment that does the opposite of what neoliberalism claims to 
encourage. “As the great political historian Karl Polanyi warned, when markets overwhelm 
society, ordinary people often turn to tyrants. In regimes that border on neofascist, klepto-
capitalists get along just fine with dictators, undermining the neoliberal premise of capitalism 
and democracy as complements. . .” (Kuttner, 2019).  
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In other words, unfettered capitalism under neoliberal principles ultimately strives for 
greater profits and fewer restraints and will undermine the interests of the majority of the country 
to do so. Costs of services such as healthcare skyrocket and little is done for those who then 
struggle to access such services, leaving them to enter financial ruin or to seek out alternatives. 
Principles of neoliberalism are meant to accommodate for such developments, with markets 
opening up to meet needs when old avenues no longer become viable. One such instance in 
which this has occurred is the inception of the modern dietary supplement market. The Dietary 
Supplement and Health Education Act (DSHEA) of 1994 permitted dietary supplements to be 
classified  as a subcategory of food that was exempt from the regulatory oversight the Food and 
Drug Administration has over food additives (Noah and Powell 2005). Additionally, “Congress 
also opted against treating dietary supplements as drugs under the Food, Drug, & Cosmetic Act 
(FDCA). In contrast to the regulatory scheme for drugs, which [theoretically] requires substantial 
pre-market evaluation of safety and efficacy before the granting of a license, DSHEA allows 
dietary supplement manufacturers to market their products without requiring any pre-market 
clearance from the FDA” (Noah and Powell 2005:860).   
This act can be viewed as the neoliberal policy that begot today’s burgeoning dietary 
supplement industry and a boon for kratom. With kratom’s classification covered by DSHEA, 
the plant was allowed to freely enter this new market to be bought and sold. However, this 
laissez faire approach has been a double-edged sword. The lack of regulatory oversite of the 
supplement market has compromised quality control. There have been several instances where 
kratom products have been found to be contaminated with salmonella (FDA, 2018) and heavy 
metals (Mammoser, 2019). It should be noted that heavy metal contamination is an issue with 
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many herbal supplements on the market, as they are often grown in countries with soil 
contamination problems (Abdulla et al. 2019). 
THE KRATOM-FDA  CONTROVERSY 
The FDA has attributed at least 44 deaths to mitragynine (FDA, 2019). The validity of 
this last point and its cases have been subject to sharp scrutiny, the most thorough of which has 
come unsurprisingly from the American Kratom Association (AKA), a non-profit group that 
seeks to meet with and inform legislators and officials about kratom to stymy ban attempts and to 
protect people’s access to it (AKA, "Our Mission"). Their response to the FDA’s report pointed 
out a litany of questionable entries to their recorded deaths list. Over half were identified as 
attributing the cause of death to mitragynine simply because it was present in the toxicology 
screen, not because it was actually ruled the cause of death (Haddow, 2018). The veracity of 
these entries ranges from dubious (multiple substances found in the system of the deceased such 
as heroin, cocaine, oxycodone and alcohol; 9 instances reported from Sweden in which the 
kratom was found to be adulterated with the prescription painkiller Tramadol) to inexcusably 
deceptive, such as suicides by hanging and gunshot victims (Haddow 2018) (FDA Adverse 
Event Reporting System, 2017).  
Overdose deaths become additionally suspect when considering that in Thailand (one of 
kratom’s countries of origin), after 100+ years of recorded use there have been no recorded 
deaths resulting from kratom intoxication (Prozialeck et al. 2019). This seems to indicate that 
kratom in its unadulterated form is not a likely source for overdose. One key difference between 
kratom consumption in the US and the countries of Southeast Asia is the utilization of 
‘enhanced’ forms of kratom available for purchase. These can range from kratom that has 
undergone an extraction process that produces higher concentrations of alkaloids to the more 
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recent development of mitragynine isolate, which is a very high concentration of mitragynine 
separated from and devoid of kratom’s other constituents. It is possible that kratom holds a 
greater mortality risk when its active ingredients are consumed in concentrations substantially 
greater than are found naturally in the plant.  
The safety of certain products related to enhancements or concentrations is not 
unprecedented in the dietary supplement market. One such product is green tea, which contains 
the catechin epigallocatechin gallate (ECGC), an antioxidant claimed to be beneficial to the body 
across many dimensions including weight loss, cardiovascular health, inflammation, and cancer 
prevention (Semeco, 2017). Following the oft-fallacious reasoning of ‘more is better’, 
supplement manufacturers sell products containing green tea extract that have concentrations of 
ECGC far higher than is naturally present in green tea. For reference, one would have to 
consume around a liter of green tea to obtain the amount of ECGC found in a 250-500mg 
capsule of green tea extract (Semeco 2017). In 2016, the Norwegian food safety agency 
announced mounting cases liver damage following green tea extract supplementation in doses of 
800mg and higher per day (Gray, 2018). Similar cases of liver damage have also been identified 
by the National Institute of Health in those taking bodybuilding and weight loss supplements, 
both of which commonly contain green tea extract in their compounds (Cooper, 2017). Several 
countries have subsequently limited or banned the sale of green tea extract, the United States not 
being one of them. To date it is still possible to find green tea extracts being sold by prominent 
retailers such as Amazon and Vitamin Shoppe in dosages close to and above the 800mg 
threshold. 
Furthermore, kratom is not alone in being a product on the supplement market that has 
been attributed to deaths. An infamous case is that of ephedrine: in 2004, the FDA mandated that 
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products containing ephedrine be pulled from the shelves. Ephedrine is the active ingredient of 
the Ephedra plant and acts as a stimulant that affects the cardiovascular system. It was frequently 
included in products advertised for promoting weight loss and improving physical performance. 
The decision to ban it came after years of reports regarding adverse side effects to such 
supplements (over 800 in all dating back to 1994) and was implicated as the contributing cause 
to at least 155 deaths (Noah and Powell 2005). The FDA’s original intention was to merely limit 
the amount of ephedrine permitted in a serving size but ultimately decided an outright ban was 
the only surefire way of ensuring public safety (Noah and Powell 2005). This complete ban was 
short lived, as “. . . a year later, a federal district court in Utah struck down the FDA rule as 
applied to ephedrine products containing 10 milligrams or fewer of active ingredient. The court 
opined that the FDA's interpretation of DSHEA’s "unreasonable risk" standard, which involved a 
risk-benefit analysis, was inconsistent with Congressional intent because it ‘places a burden on 
[manufacturers] to demonstrate a benefit as a precondition of sale, and that is contrary to 
Congress' intent’” (Noah and Powell 2005:860). This decision further demonstrates the 
DSHEA’s innate inclination to err on the side of industry when it comes to the tug-of-war 
between product manufacturers and regulatory bodies and goes a long way in demonstrating how 
little reach the FDA typically has in the field of dietary supplements.  
The most problematic issue related the oversight and safety of supplements is the lack of 
mandated quality control. The quality and quantity of a supplement can vary greatly from brand 
to brand. One investigation from the FDA even found that some store brands of herbal 
supplements from major retailers such as GNC, Target, Walmart and Walgreens did not contain 
the product it claimed to have at all, instead consisting of nothing more than inert fillers such as 
rice powder, asparagus and ground houseplant (Cameron, 2015). 
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The FDA mandates that supplement manufacturers must be in compliance with its Good 
Manufacturing Practices guidelines, which means they are “ . . . required to establish their own 
quality standards for manufacturing processes, packaging, storage, and ingredient testing, and 
must properly document that these standards are being met.” However, “. . . the FDA does not 
test the products or provide the specific definitions of what is considered appropriate for a given 
product or process” (Pharmacy Times, 2014). This means that while manufacturers must set 
standards and guidelines, they are not routinely being checked for whether they are following 
through with them. In effect, the guidelines are just that: guidelines. 
All of this is to say that when it comes to dietary supplements, the onus of research and 
risk assessment largely falls on the consumer. Oversight bodies, in effect, can only react when 
confronted with potentially harmful products and questionable manufacturing procedures. Even 
then, regulatory agencies have little legal recourse to take meaningful action. Knowledge of this 
lack of robust consumer protection strategy in the dietary supplement market might lead 
consumers to believe that they are assuming less risk in seeking out prescription pharmaceutical 
drugs rather than holistic products on the loosely regulated supplement market, where quality 
and efficacy are not guaranteed. But here too the standards of risk assessment are not what they 
seem.  
KRATOM, THE FDA AND THE “RISK SOCIETY” 
The concept of “risk society” has been put forth both by Anthony Giddens and Ulrich 
Beck, but for the purposes of this discussion Beck’s conception will be the primary focus. It 
argues that as societies have modernized and changed, so too has the nature of the risks its 
members face both in how they are navigated and dealt with. Both sociologists observed that 
modernity has brought a preoccupation with the potential of the future rather than any focus on 
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immediate issues, particularly in the case of managing the consequences of environmental 
destruction in the pursuit of science and business. Beck states that it is the very methods used to 
reach modernity—attempting to bend nature to our will in order to overcome problems of 
scarcity—that has promoted the existence of the new kinds of risks now faced in the modern age 
(1992). The simplest example of this phenomenon is that of food scarcity: In many developing 
parts of the world hunger and famine are still very real threats to survival, whereas in 
‘modernized’ societies it is the overconsumption of food (i.e. obesity and diet-related diseases) 
that has largely taken its place. The pesticides used on crops, the immense amount of land and 
resources required for raising livestock and the greenhouse gases they produce, as well as the 
chemical additives put in food are additional examples of the sort of consequences being 
analyzed in his work. 
As it pertains to medicine, Beck posits that innovations are often allowed to develop 
freely with little oversight or regulation: 
“Despite all the criticism and skepticism regarding progress, what 
continues to be possible, even taken for granted, in the area of medicine would, if 
transferred to official politics, be equivalent to the scandal of simply 
implementing epoch-making fundamental decisions on the social future, while 
bypassing the parliament and public sphere, and making debate on the 
consequences unreal by virtue of their realization in practice. This need not even 
express a failure of the moral quality of science. According to medicine’s social 
structure, there is no parliament in the sub-politics of medicine, and no executive 
branch where the consequences of the decision could be investigated in advance” 
(1992:208). 
 
Applied to pharmaceutical industry, the point being made here is that there are no longer 
any adequate checks and balances on the production of prescription drugs. The pharmaceutical 
industry by their own efforts and the lack of true understanding of current drug testing and 
development processes by members of Congress has effectively allowed them to push drugs of 
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dubious efficacy and unknown (or concealed) risk to market. The mechanisms to keep them in 
check are technically in place but have been thoroughly compromised due to the far-reaching 
influence the pharmaceutical industry has both on Congress and the FDA. In 2019, the 
pharmaceutical industry spent $295 million dollars on lobbying efforts—almost double the 
amount of the second biggest spender ($156 million), the electronics manufacturing and 
equipment industry (Duffin, 2020). Additionally, Caroline Chen’s exposé on the seemingly quid 
pro quo relationship that has formed between the FDA and the pharmaceutical industry revealed 
damning statements made by former FDA employees about the degree in which the agency is led 
around by Big Pharma as the result of its lobbying efforts in Congress:  
“’You don’t survive as a senior official at the FDA unless you’re pro-
industry,’ said Dr. Thomas Marciniak. A former FDA medical team leader, and a 
longtime outspoken critic of how drug companies handle clinical trials, Marciniak 
retired in 2014. ‘The FDA has to pay attention to what Congress tells them to do, 
and the industry will lobby to get somebody else in there if they don’t like you.’ 
Staffers know ‘you don’t get promoted unless you’re pro-industry,’. . .” (Chen, 
2018). 
 
Some members of the upper echelon of the FDA were not afraid to openly admit this 
uneven power balance while still employed there. During a 2015 agency forum, one slide in a 
presentation explicitly stated  “User fees pay for services that directly benefit fee payers,” with 
FDA representative from the agency’s negotiating team Theresa Mullin adding, “And because 
it’s a fee, it’s really intended to benefit directly . . . the fee payers and benefit them in a way 
that exceeds the benefit to the general public [emphasis added]. . .” (Hilzenrath, 2016). It is 
not just their current occupation employees are considering when they bow to the pressure to 
abide by the pharmaceutical industry’s will—they also have to consider their future employment 
once they decide to move on from the FDA, which for many means working in the 
pharmaceutical industry. The migration of employees from the FDA to the pharmaceutical 
 
 20 
industry has been described as a ‘revolving door’. One study done looked at 55 medical 
reviewers for the FDA who worked with haematology-oncology related drugs and the approval 
of such drugs from 2006-2010, cross-referenced it with a collection of medical reviews from the 
agency’s database from 2001-2010 and then looked at what job the reviewers had in that nine-
year span. “The researchers found that among 55 people who worked as haematology-oncology 
medical reviewers from 2001 to 2010, 27 continued in their roles at the FDA, two people worked 
at the FDA but held other appointments, and 15 left the FDA to work with or consult for the 
biopharmaceutical industry. The jobs of the rest of the people could not be determined” 
(Sifferlin, 2016). 
The rate at which this occurs at the very top of the FDA’s hierarchy is even more 
alarming. Nine out of the last ten heads of the FDA went on to work at pharmaceutical 
companies (Foley, 2019). The pharmaceutical industry also participates in de facto (though not 
legally applicable) bribery to gain favorable outcomes in the drug approval process. The FDA 
has statutes in place that forbid employees from accepting gifts in any form and are (alongside 
physicians who are invited on) expected to reveal any potential conflicts of interests they may 
have before joining a review board for any given drug or therapy. These safeguards have two 
fatal flaws: the first is that bringing to light conflicts of interest relies almost entirely on the 
honesty of the members of the panel. The second is that pharmaceutical companies work around 
these rules by instigating something described as “pay-later conflicts of interest”, which the 
current conflict of interest rules were not structured to include (Piller et al. 2018). 
The FDA’s culpability in the Opioid Epidemic by way of ineffective policing of the 
pharmaceutical industry has grown more apparent over time. Former member of the FDA 
advisory committee overseeing the approval of new opioid drugs, Dr. Raeford Brown described 
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the agency as  having “a willful blindness that borders on criminal” in regard to its continued 
approval of narcotic painkillers in spite of the growing number of dead and addicted opioid users 
(McGreal, 2019). The FDA’s general response to opioids over the years can be described as ‘too 
little, too late’ and with great inefficiency. One such example being their commissioning of a 
program in 2010 to better educate doctors on prescribing narcotic painkillers that they designed 
so poorly they could not properly determine whether or not the programs had any efficacy 
(Goodnough and Sanger-Katz, 2019). A later investigation by the agency’s parent organization, 
The Department of Health and Human Services determined that just 14% of these programs met 
their targeted goals (Levinson, 2013).  This has been attributed to the fact that pharmaceutical 
companies were put in charge of their own oversight regarding data collection to support their 
programs’ efficacy but often included an insufficient amount of data for outside parties to make 
accurate assessments. A later DHHS report would note that the problem was further complicated 
by the FDA’s lack of authority to take enforcement actions against manufacturers who did not 
provide an adequate amount of data (Sullivan, 2019). 
Despite more pronounced efforts to understand trends and curb the dispensing of opioids 
in recent years, the FDA persists in having a contradictory approach to the class of drugs. In one 
action they promised to fast-track opioid alternative painkillers and to limit access to opioid 
through the SUPPORT (Substance Use-Disorder Prevention that Promotes Opioid Recovery and 
Treatment) Act (Kent, 2019) while in another they approved the drug Dsuvia, an opioid stronger 
than fentanyl which it had initially rejected in 2017 only to approve it when it was resubmitted 
the following year (Sullivan, 2019). 
Regardless of how well the public is informed about the details of the FDA’s policies, 
practices, and close relationship with the pharmaceutical industry (pertaining to the opioid 
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epidemic or otherwise), their opinions of both entities have soured to say the least. In a 2020 
Axios-Ipsos poll, a majority of Americans (57%) said they have some degree of trust in the FDA 
but 42% stated that they have little or no trust in the agency at all, while a majority (57%) of 
those polled said they had little or no trust in the pharmaceutical industry (Talev, 2020). A 2019 
Gallup poll found the pharmaceutical industry to be in dead last out of twenty-five other 
industries in terms of favorability in the eyes of Americans, 58% of which viewed the industry 
negatively and 27% positively (McCarthy, 2019). 
Given the compromised role of the state to help determine and mediate risk involved with 
pharmaceutical drugs, it is no surprise that many Americans prefer to try and go their own way 
through the use of dietary supplements rather than subject themselves to the products of the 
pharmaceutical industry. The 2002 National Health Interview Survey found that 18.9% of US 
adults had taken non-vitamin/non-mineral supplements in the past year, with an expectation that 
inclusion of vitamins and minerals would bring the figure considerably higher (Nichter and 
Thompson, 2006). This claim bears out in another survey revealing that 86% of American adults 
take some form of vitamin or supplement (American Osteopathic Association, 2019). Women, 
especially those who are white and middle class, are the most prominent demographic of 
supplement users. Additionally, higher levels of educational attainment appear to correlate to an 
increased likelihood of supplement use (Nichter and Thompson. 2006).  
Motivations for general dietary supplements use are varied and numerous. The 
motivation to utilize them due to distrust of mainstream medicine and medical authorities, 
particularly on their general consensus of supplements was detected in the Nichter and 
Thompson study, who found that “Several of the supplement users we interviewed seemed 
somewhat ambivalent about, if not skeptical of, scientific assessments of supplements—with a 
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few informants suggesting that conventional medicine has its own agenda for negatively 
evaluating supplements and discrediting other healing systems, namely, because of the close ties 
between the pharmaceutical industry and conventional medicine and to reinforce biomedical 
authority over alternatives”.  Nichter and Thompson go on to say, “They [the supplement users] 
perceived these practitioners to be engaging in ‘boundary work’ that entailed defining the ‘other’ 
in negative terms. Scientific evidence about supplements was received with some degree of 
latitude” (2006:208). 
Nichter and Thompson attribute this sort of thinking to an overarching phenomenon 
taking place in society in which science’s ‘monopoly on knowledge production’ is called ever 
more into question as “. . .people are open to the possibility of multiple and differential sources 
of knowledge” due to “lay involvement in the coproduction and evaluation of knowledge” 
(2006:200). One can speculate that this way of thinking is a consequence of the modern risk 
society and was catalyzed by the ubiquity of the internet and the fertile ground it provides for 
disseminating dissenting opinions towards various subjects such as mainstream versus alternative 
medicine.  
The Nichter & Thompson interviews also discovered that this apprehension did not 
simply compel supplement users to shun modern medicine and accept alternative medicine 
without question. The risk society element to the big picture becomes apparent once again, as 
those interviewed held suspicions about supplements as well and sought out methods for 
determining their safety and veracity for themselves.  
“Most of the supplement users we interviewed struck us as being cautious, 
if not skeptical, consumers of public information—not passive consumers 
accepting information at face value. Informants maintained doubts about both 
product promotional literature and product quality. They came up with their own 
litmus tests for measuring safety and quality such as the ‘Costco test’ or by 
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equating cost with safety quality. Few informants rejected biomedicine and most 
thought that ‘amazing breakthroughs are occurring in science all the time’. On the 
other hand, they did not feel that conventional medicine was a panacea, and many 
suspected that some biomedical practitioners and researchers rejected CAM 
[complementary and alternative medicine] modalities, including dietary 
supplements, ‘out of principle, not practice.’’ (2006:208) 
 
The principles of risk society are apparent. People are less inclined to simply believe 
what they are told, no matter the source of the information, than they may have half a century 
ago. The subsequent analysis of the discussions on the kratom subreddit tend to be reflective of 
the data surrounding supplement users in general, with a theme arising from a portion of the 
interactions where users cautioned against seeing kratom as a decisively safe and risk-free 
substance, instead advocating for a more balanced perspective that although kratom does have 
some risks, they have determined for themselves based on the information they have accrued that 
its safety profile is preferable to that of the prescription alternative they would require for their 
condition. 
There are other areas of consistency between the motivations for general supplement 
users and using kratom specifically. This is not inherently surprising, but it does speak to the 
nature of kratom usage and indicates a contradiction towards the scenario conjured up by 
detractors of the substance as being nothing more than a legal alternative to narcotics for 
recreational drug users. Other parallels that arose between the Nichter & Thompson study and 
the analysis of the Reddit posts are as follows:  
“Our research suggests that most supplement use is pragmatic. Nevertheless, the 
popularity of dietary supplements also reflect American values of personal responsibility 
and individualism. . .Supplement use, for others, is a search for an alternative diagnosis 
for a health problem. . .supplement use is a means of gaining a sense of control. . 
.supplements are a means of self-care, reminding people to think of themselves on a 
regular basis. . .Supplement use is a means of harm reduction for those living in what is 
perceived to be an unhealthy environment, as well as for those who have adopted 
unhealthy habits. For those who see their disease treatment by conventional medicine as 
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simultaneously having negative health effects on the body, dietary supplements may also 
be utilized as a form of harm reduction. Others are using supplements in order to ‘save’ 
potent drugs for when they need them most or to avoid dependence on potentially 
addictive conventional medicines” (2006:206-207). 
 
Matters of self-reliance, self-care, and an aversion to conventional medications in the 
interest of harm reduction and addiction avoidance are all prevalent aspects of the discussions 
that took place on the kratom forums analyzed. Kratom is seen as a medicinal botanical that does 
not require doctors or insurance to access and has fewer side effects than prescription drugs 
while not feeling as ‘heavy duty’. The healthcare system is largely viewed with great antipathy 
by those who have opted to use kratom in a therapeutic capacity. This is in part due to many of 
these people having chronic pain and being put on prescription opioids to manage it. Some claim 
that their prescribers would not allow them enough medication to successfully manage the pain, 
while others found their growing dependency on pills to be unsettling. In the end it is a desire to 
make a clean break from doctors and pharmaceuticals that leads many such people to utilize 
alternatives such as kratom. 
ORIGINS OF THE AMERICAN PHARMACEUTICAL INDUSTRY 
Two of the earliest founded pharmaceutical companies in America were Pfizer, Eli Lilly, 
and Bristol Myers Squibb, which were started in 1849, 1876 and 1858, respectively. The 
American Civil War was a boon to the budding pharmaceutical industry, as the demand for 
painkillers was high (Pharmaphorum, 2020). Further opportunities for American pharmaceutical 
companies arose with World War I, the result of which destabilized the German pharmaceutical 
powerhouses Merck and Bayer and toppled the country from its position of dominance in the 
pharmaceutical industry. The years of interlude between the world wars would see the 
conception of two new groundbreaking medications, insulin and penicillin. Penicillin would lend 
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itself to propelling the pharmaceutical industry to even greater heights as its necessity reached a 
fever pitch during World War II, likely saving the lives of countless soldiers (Pharmaphorum, 
2020).  
It was during the postwar period that pharmaceutical companies grew to be the industrial 
giants they are known as today. The newly formed National Institute of Public Health began 
giving millions of dollars in funding to begin filling the vast void of diseases and medical 
conditions without treatments or cures. In addition to government funding, the industry was also 
helped along by a high demand for prescription drugs due to circumstances of soaring population 
growth, rising standards of living, and an organized market thanks to the advent of health 
insurance (Malerba and Orsenigo, 2015). The United States’ unique patenting laws for drugs 
allowed the product itself to be protected rather than the process of producing it, unlike in many 
other developed countries (Malerba and Orsenigo, 2015). This allowed pharmaceutical 
companies to have a stranglehold on new drugs for twenty years (Berger et al. 2017), keeping 
their cost to consumers high. 
The postwar years up until the 1980s are considered the “Golden Age” for 
pharmaceutical discovery and sales, seeing the inception of birth control, antidepressants, 
anxiolytics, ACE inhibitors and anti-cancer drugs (Pharmaphorum, 2020). These breakthroughs 
would culminate in an important milestone for pharmaceutical companies, setting the historical 
precedent for the majority of their profits being attributable to ‘blockbuster drugs’ of esteemed 
value due to efficacy or lack of alternatives. The first major blockbuster drug was the ulcer 
medication Tagamet, which was solely responsible for netting its manufacturers $1 billion a year 
in sales (Pharmaphorum, 2020). Within the golden age came greater regulation, in part due to the 
public funding received as well as infamous cases such as that of thalidomide. Thalidomide was 
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a sedative drug sold over the counter that became immensely popular due to being touted as a 
completely safe substance and later being found to alleviate morning sickness in pregnant 
women, leading to an increasing number of these women taking it. It was not until later when 
cases of babies being born deformed mounted that it became widespread knowledge that 
thalidomide had a high likelihood of causing birth defects, leading to more stringent rules 
regarding proof of safety and restrictions on the ease of access to some drugs (Fintel, Samaras, 
and Carias 2009). 
Today the pharmaceutical industry is more profitable than ever. Between the year 2000 
and 2018, the 35 largest pharmaceutical companies earned a combined revenue of $11.5 trillion 
with an estimated $8.6 trillion being in profit—a figure almost twice as high as that of 357 other 
non-pharmaceutical S&P 500 companies (McCall, 2020). Though the rate of new pharmaceutical 
drugs has slowed in recent decades, pharmaceutical companies have evolved to branch into new 
mediums of medicine. Immunotherapy and gene therapy are the new horizon for the industry to 
combat rare or difficult to treat illnesses, though the rise of antibiotic-resistant bacteria and 




III. METHOD  
The method of content analysis was applied for analyzing the forum threads. Content 
analysis is suited to “. . .organize and elicit meaning from the data collected and to draw realistic 
conclusions from it” and “. . .provides a systematic and objective means to make valid inferences 
from verbal, visual, or written data in order to describe and quantify specific phenomena” 
(Bengtsson, 2016:8-9). Given that the data being analyzed was derived from an online forum, 
content analysis was best suited to the purpose of this study. 
Content analysis is generally done in four stages: Decontextualization, 
Recontextualization, Compilation, and Categorization. Decontextualization is the process of 
coding potentially important words and phrases in order to catalogue them. Recontextualization 
involves re-reading the material in order to ensure nothing uncoded that could be of relevance to 
the research question is left out or confirming if it is in fact unneeded. The categorization stage is 
when data begins to get grouped together based on the common elements or themes they share 
and may generate sub-categories or sub-themes (Bengtsson, 2016). The final stage of 
compilation is when analysis of the data occurs. Analysis may be done in a latent or manifest 
manner, with latent analysis allowing “. . .the researcher to immerse him/herself to some extent 
in the data in order to identify hidden meanings in the text. For each category or theme, the 
researcher chooses appropriate meaning units presented in the running text as quotations” while 
manifest analysis “. . .often uses the informants' words, and he/she remains aware of the need to 




REDDIT AND THE CODING AND CATEGORIZATION OF REDDIT DATA 
Reddit is an aggregation site where users post links, images, gifs, videos and have 
discussions on every conceivable subject, with ‘subreddits’ being forums dedicated to specific 
topics of interest. Comments and posts can be upvoted and downvoted, which determines how 
prominent the posts and comments will be. Posts with a very high number of upvotes may break 
out onto the site’s front page, which displays the most popular posts on the site from any 
subreddit. If a subreddit does not exist for a topic, users may create one themselves. The age 
demographic breakdown of US adults reported as being Reddit users is as follows: 23% aged 25-
29, 21% aged 18-24, 14% aged 30-49, 6% aged 50-64 and 1% aged 65 and over (Lin, 2020). My 
own poll asking about age posted specifically to the r/Kratom subreddit yielded a distribution out 
of 246 respondents of 4% being younger than 18, 33% aged 18-24, 35% aged 25-34, 25% aged 
35-54, and 3% aged 55+ (To view the poll, see Appendix A). Reddit is the 9th most visited site 
on the internet and the 3rd most visited ‘social media’ site, behind Facebook and Twitter 
(Hardwick, 2020). These facts, paired with my familiarity with the site and prior knowledge of 
its kratom forum and its preeminence as one of the major places of discussion for kratom users, it 
was an obvious choice. The only other site with groups similar to Reddit’s kratom forum is 
Facebook, and the most popular group there has only a few thousand members which dwarfs the 
tens of thousands of members that were on Reddit during the time of the kratom ban. 
Reddit is also a common social sphere in which sub-political actions of resistance are 
manifested and carried out. The most high-profile of these actions is the most recent usurping of 
Wall Street trading by the subreddit r/WallStreetBets, who by collective action bolstered the 
value of Gamestop stock and cost hedge funds that were attempting the short sell it billions. 
Reddit’s knack for facilitating such acts of resistance towards authority and the status quo made 
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it that much more appealing for analysis regarding what was accomplished against the DEA’s 
bid to schedule kratom. Although the age demographic of the kratom subreddit is skewed 
slightly older than the demographic of Reddit overall, the age of the users as well as Reddit 
users’ general tendency to be anti-authority may skew the data on the motivations and beliefs of 
kratom users at large. 
The forum on Reddit dedicated to the discussion of kratom, r/Kratom, is a hotbed for 
communication both between kratom users and organizations such as the American Kratom 
Association, a non-profit organization that seeks to meet with and inform legislators and officials 
about kratom in order to stymy ban attempts and to protect people’s access to it (AKA, "Our 
Mission"). This subreddit is a key platform in which people stay informed about the latest 
developments regarding kratom, be it discussions on methods of consumption, strains and 
variants, or news on the latest fight for its legality. Boasting nearly 110,000 members (108,851 
as of this writing), it is the preeminent source for checking the pulse of the kratom user 
community. 
Because of its value, I decided to utilize Reddit as a source of my data. I engaged in a 
content analysis of posts to assess the motivations and attitudes of kratom users as they pertained 
to their relationship with the oppositional forces (such as the DEA and FDA) seeking to ban 
kratom. The DEA ban was first announced August 30th, 2016 and withdrawn on October 13th, so 
I pulled the top 200 most commented on posts from August 30th 2016 to October 30th 2016 and 
compiled them into the AtlasTI program. Posts from this period of time were located by using 
the Redditsearch.io archival search site, which allows users to search specific subreddits to show 
what its most popular posts were in a given period of time. Amongst the posts related to the 
kratom community’s efforts to fight the DEA decision were ones pertaining to the subreddit’s 
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daily mundanities like product reviews, kratom utilization advice, and vendors advertising 
upcoming sales. Posts of this nature were not analyzed due to a perceived lack of relevance for 
this research. Only posts and comments on the posts were analyzed. Replies to comments on the 
post were generally only statements of agreement rather than additional sentiments or dissenting 
opinions and were thus of little practical value to the research. 
Of the 200 posts harvested, 148 (73%) of posts were irrelevant/discussions unrelated to 
news regarding the DEA ruling. Of the 48 relevant posts, 11 (23%) contained themes of 
anxiety/fear of regression, 19 (35%) contained themes regarding personal liberty/treatment 
agency, and 34 (71%) contained themes of disdain and distrust of regulatory agencies and the 
pharmaceutical industry. Discussion threads often contained individual responses that 
exemplified different thematic elements.  
The relatively small number of posts relevant to the study versus the total number of 
posts gathered may at first seem delegitimating. However, there are circumstances that inflate 
this contrast. As briefly mentioned, at this point in time on the subreddit kratom vendors were 
permitted to advertise and were enthusiastic about doing so in order to advertise directly to 
prospective buyers. Because of this, many posts are simply companies’ advertisements for new 
inventory, sales, and other things of this nature. There is also a distinct possibility that the 
frequency of these ads increased when it looked like kratom was going to be banned, as it would 
be imperative for vendors to move inventory before they were stuck with it. Adding on posts that 
were just about ordinary discussion topics regarding kratom (vendor and strain reviews, how 
much kratom to take, how to take it, etc.), the grassroots rallying posts are pushed to the margins 
in terms of their numbers. However, the volume and frequency of discussion on activism related 
posts was far more substantial than on any of the other threads, providing a sprawling amount of 
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information and commentary that made up considerably for the comparatively low total number 
of related posts.  
Using ATLAS.ti, I began the process of open coding using keywords that were most 
likely to pinpoint threads and responses that were relevant to the discussion of kratom’s fight for 
legality against the DEA and all matters related to it. Some words and phrases were related to the 
motivations people have for using kratom, while others were terms that referred to the entities 
involved in trying to halt the sale of it.  These were phrases such as ‘Big Pharma’, ‘FDA’, 
‘DEA’, ‘Addiction’, ‘Heroin’, ‘Medicine’, ‘Mental health’, and ‘Withdrawal’ (See Appendix A 
for a complete list of words/phrases). Having already known the sort of content I would find, 
these words were coded to seek out the preexisting themes embedded in the posts rather than as a 
general dragnet.  I then reviewed the posts that contained any of these terms for relevance and 
context and sorted them as being ‘potentially relevant’ or ‘irrelevant’. The axial coding phase 
then began, with potentially relevant posts read through to gain context and to understand the 
narrative. From this, common themes began to show themselves that were relevant to the 
elements of Beck’s Risk Society and usually entailed personal and political anxieties that could 
be attributed to the United States’ neoliberal policies in its handling of healthcare, regulation, and 
legislation. Through selective coding, the common elements were then consolidated into three 
major themes that best accommodated the recurring elements observed. The primary themes and 
patterns found were ultimately sorted into three (3) categories:   
1) “Desire for Treatment Agency and Personal Liberty” or an expressed 
belief in the right for people like them to utilize substances outside of the purview 
of mainstream medicine to self-treat conditions.  
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2) “Fear of Regression and Return to Risk” anxieties expressed about what 
users would do in the event that kratom was ultimately scheduled and banned, 
fearing having to get back on prescription painkillers or relapsing into their old 
addictions.  
 3) “Disdain and Distrust of Regulatory Agencies and Pharmaceutical 
Industry” regarding a sense of antipathy towards organizational bodies such as the 
Drug Enforcement Administration and the Food and Drug Administration. This 
involved a deep-seated conviction that these agencies such as the FDA act against 
kratom not out of a concern for public health and wellbeing, but at the behest of 
the pharmaceutical industry who they presume do not wish to see treatments 
outside the control of Big Pharma for conditions such as chronic pain become 
commonplace.  
In addition to locating the pertinent comments, the coded words and phrases also 
served to help ‘line up’ the three themes conceived. Looking for the posts that discussed 
matters of addiction, drugs that likely fueled that addiction, and comments about the 
FDA, DEA, and Big Pharma revealed context that pointed to sentiments rife with fear, 
anxiety, a profound sense of distrust and antipathy towards governmental bodies and the 
pharmaceutical industry, as well as a strong desire to be left to ones own devices to look 
after oneself in treating medical issues. Identifying these traits are what ultimately led to 
the construction of the three umbrella themes conceived of for this analysis. 
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IV. DATA ANALYSIS, FINDINGS AND INTERPRETATION 
In this section, each theme will be individually presented and analyzed through 
the forum excerpts that best represent them. They will demonstrate how these three 
primary themes came to be conceived of and the meaning derived from them will be 
discussed. Themes of resistance begin to surface, as will their connection to aspects of 
risk society.  
The excerpts are rife with equal parts indignation towards the government and 
fear about what will happen if the kratom ban goes through. There is also a strong air of 
what would best be described as jaded disbelief: exasperated pointing out of how ‘anti-
American’ the intention is to restrict people’s liberty to ingest what they feel is a safe and 
beneficial plant that does not impact anyone but themselves. The kratom ban in their eyes 
is the epitome of an anti-democratic, corrupt government that has been insidiously 
lurching towards this point of authoritarian rule. The most astounding find at the center of 
these comments is the most likely culprit is unveiled while people are pointing their 
fingers in the wrong direction. 
Forum users unwittingly demonstrate that the long-peddled neoliberal promise of 
greater freedom with less government was only ever applicable to corporate entities and 
the economic elite, accomplished by shafting the common citizen. Neoliberalism was 
sold to the nation at large by trumpeting rugged individualism and personal liberty 
through free markets while making claims that government overreach is the bane of 
liberty, and many Reddit users seize upon this point while simultaneously making 
accusations that the pharmaceutical industry is calling the shots behind the actions of the 
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FDA and DEA. It is in fact the defanging of governmental regulatory power over the 
industry coupled with the permittance of corporate interests to have substantial political 
influence that has produced the conditions that made government so susceptible to 
carrying out the will of entities such as Big Pharma under the auspices of public interest.  
THEME 1: DESIRE FOR TREATMENT AGENCY AND PERSONAL LIBERTY 
“It's crazy to think about the government making a plant that grows on its 
own in nature illegal. Who do they think they are?” (JuicyJay, 2016)  
“If what I've been reading is true about the HMFIC [Head Mother Fucker 
in Charge] of the DEA then it's all about big Pharma screwing us out of our 
ability to take care of ourselves. Enough is enough! There's no theory involved. It 
IS a damn conspiracy [emphasis added]” (66asswhuppin1, 2016). 
“I just want to be left the fuck alone. That's it. I, as a consenting level 
minded (I think) adult, wish to be able to choose what substances I wish to put in 
my body. Obviously there is a limit to this if you believe in a civil society. Deadly 
highly addictive drugs like meth, coke, heroin, etc. I can get why those are 
outlawed. But going after fucking plants like MJ [marijuana] and Kratom is 
insanity. Not only because they're being made illegal, but because they're being 
listed as a SCHEDULE 1 fucking drug??! Is this a god damn joke? Isn't this the 
United States of America? Supposedly the most free country on earth!? Now those 
in possession of an herbal plant become Felons after 9-30-2016?” (QuenHen219, 
2016). 
 
The quotations presented above display a strong belief that these individuals should have 
the right to choose the path they wish to go down regarding the treatment of their conditions. 
Many found the intended legislation to be an affront to this right. This stems mainly from the 
third theme found: the perception that the regulatory agencies are not basing their decisions on 
any real empirical data or concern for public health. Rather, that it is being done to reroute these 
individuals back into the fold of using pharmaceutical drugs. As such, their trust in the State on 
such matters is minimal, since the arms of the State have in their eyes been repurposed to serve 
the interests of the pharmaceutical industry and for the personal gain of the agencies themselves.  
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 “This pises [sic] me off to high heaven. I was a fucking alchoholic [sic] 
for 20 years. Now that damn near killed me. That’s a dangerous drug! But it can 
be taxed and its scocially [sic] acceptable? Kratom I’ve been taking for years, it 
kills my pain, and gets me out the door to work in the morning. Who the fuck is 
the DEA or any other people pushing this ban, to tell me what I can put in my 
body. This is a plant were talking about? It groes [sic] out of the earth, therefore 
an herb or botanical. . .Or if there [sic] so fucking worried, make it 21 and over 
like booze, which kills thousands, and destroys lives by the millions. . .I don’t 
need daddy or mommy telling me what I can eat or drink. Again I say its an herb 
in the powdered leaf form, therefore a supplement, and if you don’t think its safe 
don’t take it? Like I said they could meet in the middle,21 and over, if there [sic] 
worried about the kids? Responsible adults should have access to natural 
medicine if it has not been altered or modified, its just a plant. Also they better get 
ready for an opiate epidemic like they’ve never seen before, cause people depend 
on kratom for all types of pain, and there going to use something else?. . .Think 
about that, DEA Your [sic] going to trade a safe botanical, for death and 
destruction, why??? To show America who’s in charge. Americans, don’t need 
daddy telling them what there [sic] allowed to eat and drink. And I’m not going to 
live in pain, because you aren’t sure if I’m safe. It’s about control, and everyone 
knows it. Not to mention big pharma can’t patent a plant!” (BuckSteel771, 2016). 
 
From these and other excerpts it is patently clear that the DEA announcement of their 
intent to place kratom into the Schedule 1 category of controlled substances was felt by many 
kratom users as a direct and personal affront to themselves and their rights. How closely this 
sentiment is tied to a sense of distrust towards the governmental regulatory bodies involved and 
cynicism regarding their motives is apparent in the statements provided. In conjunction with 
surveys indicating that confidence in regulatory bodies such as the FDA is diminishing, a crisis 
of trust is a staple feature at the heart of the kratom controversy at play. Crises of trust are also a 
feature of risk societies, stemming from the loss of preeminent authority that occurs when the 
State and other authoritative bodies lose their grip on the monopoly of knowledge (Beck, 1992). 
This loss of confidence in the guidance of authority was also present in the study involving 
supplement users in general. Nichter and Thompson conducted a study interviewing dietary 
supplement users to discern their beliefs and motivations that led them to using supplements and 
an overarching trend of growing crises of trust was found there as well (2006).  
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“I am not going to follow this law...I have the right to put whatever I 
choose into my body because it is MY BODY. This body does not belong to the 
federal government. I am not property. I don't need someone from the shadows, 
who I know for a fact doesn't have the qualifications to make decisions about 
what I can do with MY own body. Sure, science based research is necessary. I 
have done research online; I trust society. I have confidence in our judgment as 
rational adults to make those decisions. That works for me. There is also market 
here. Money is good for us. Money is also good for United States. The DEA has, 
in what appears, poised themselves to be actively working in the guise of public 
safety to make financial plays for the pharmaceutical industry. Essentially 
destroying an entire market for natural medicine. This stance is Anti-Capitalism 
and Anti-American. We are being painted as criminals for making adult decisions 
in increasing the quality of our lives. This is a direct threat to our liberty. I am 
insulted. I have been disrespected. A voice of authority who I did not elect, who 
does not represent me has made a visceral attack on my quality of life. . .We know 
the truth and we will not let it slide past in silence without a fight. Not this time. 
Look what happened with cannabis??!!?” (NoCountryForOldMemes, 2016). 
(For more quotes related to this theme, see Appendix B). 
 
Here a ‘crisis of trust’ stems from growing cynicism towards the healthcare industry with 
a waning trust in government to counteract industry-driven subterfuge. The concept behind the 
label of ‘risk society’ is that we rely on experts to help us navigate potential harms we may incur 
in circumstances throughout our lives, but because of the sheer volume of differing perspectives 
and sources of information (combined with the growing sense of distrust of various entities and 
institutions) presented, it is ultimately up to us to decide what information to utilize. Such a 
necessity resonates strongly with Americans, because the neoliberal ideals we are steeped in 
greatly emphasize the importance of self-determination and personal responsibility in securing 
our own wellbeing.  
Aside from the practical barriers of healthcare costs and the potential scarcity of doctors 
in a given location is a phenomenon borne out of our development into a risk society. Beck 
believed that the way in which people interact with the profession of medicine has changed 
substantially from the past couple centuries up to the contemporary period. When the area of 
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medicine became a more standardized and professionalized field in nineteenth century Europe, 
patients would enter hospitals to be assessed and healed by physicians while remaining ignorant 
to what the cause of their affliction was and how the actions taken by doctors remedied it (1992). 
He goes on to say: 
“Today, conversely, the sick, who were systematically made and kept 
ignorant in dealing with their illness, are being left to themselves and other 
institutions, also totally unprepared for them: the family, the occupational world, 
schools or the public sphere. . .As a result of diagnostic ‘progress’ also, disease is 
being generalized [emphasis the author’s]. Anything and everything is ‘sick’ or 
can actually or potentially make one ‘sick’—quite independently of how a person 
actually feels. Accordingly, the image of the ‘active patient’ is being brought out 
again; demands are being made for a ‘working alliance’ in which the patient 
becomes the ‘auxiliary doctor’ for the state of illness ascribed to him by 
medicine” (Beck, 1992:205). 
 
Here Beck’s prime example in mind for this shift is that of the AIDS epidemic, in which 
the field of medicine could successfully determine what the afflicted was suffering from but had 
yet to have any efficacious treatments for it, leaving the afflicted to make do with whatever 
generally inadequate support systems they had available. The conditions kratom purportedly 
treats are not quite so hopeless or deadly as AIDS was in the 80s; addiction, chronic pain, and 
many mental illnesses have various pharmaceutical and therapeutic options available to attenuate 
the suffering they cause. Kratom users’ desire to be their own ‘auxiliary doctor’ here is due not 
because the medical profession has no options for them, but because they feel that the options 
offered have been ineffective, expensive, or carry too heavy a side effect profile that causes the 
cons to outweigh the pros. Assurances made about these options, whether it be in terms of safety, 
efficacy or both has led these people to feel lied to or taken advantage of. When combined with 
the deluge of dissenting voices and alternative suggestions, crises of trust inevitably develop and 
 
 39 
the compulsion for the individual to manage their own decisions or actions on medical matters is 
encouraged by the tenets of neoliberalism.  
It is because of these tenets that many people use supplements as a form of harm 
reduction; It is a way in which an individual can personally handle taking measures against 
exposure to harmful or risky elements in their life whether the source be environmental, genetic, 
or lifestyle based. This helps to produce a sense of control or mitigation of these risks in 
circumstances where they might otherwise feel powerless. An example used by Nichter and 
Thompson is of working or living in an environment contaminated by pollution: risk could be 
reduced by environmental legislation intended to improve these conditions, but this would 
require the cooperation of industries and members of government, many of whom would actively 
try to prevent such legislation from passing. Instead of dedicating time and effort towards this 
Sisyphean task, a person could in theory just take supplements that are supposed to cleanse the 
body of free radicals or toxins and provide themselves personal and immediate aid against the 
threat this macro-level condition poses to them (2006). 
For kratom users, the macro-level threat stems from the once-hidden dangers of 
pharmaceutical drugs (namely narcotic painkillers) and the failures of the FDA to properly assess 
and police the pharmaceutical companies and their products, leaving it to them to seek out their 
own treatment whether it be for chronic pain, addiction or otherwise. The suppression of the 
addiction potential of these drugs and the epidemic levels of addiction that followed more liberal 
prescribing practices of said drugs. In the realm of risk society, this can be considered a ‘latent 
side effect’.  
“Risks can be legitimated by the fact that one neither saw nor wanted their 
consequences. Risk positions first have to break through the protective shield of 
taboos surrounding them, and ‘be born scientifically’ in scientized civilization. 
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This generally happens as the status of a ‘latent side effect’. Which 
simultaneously admits and legitimates the reality of the hazard. What was not 
seen could not be prevented, was produced with the best intentions, and is an 
unwanted problem child of the objective in mind” (Beck, 1992:34). 
 
Beck’s contention that consequences cannot be known in advance is applicable to 
innovations like new prescription drugs, where additional risks are often undetected until after 
the drug has been put on the market. This is especially true in the United States given how 
lackluster the assessment process has come to be. A number of substances have managed to pass 
muster only to be pulled from the market years later due to previously-unknown side effects 
(ProCon.org, 2014). Sometimes this can happen simply because clinical trials are comparatively 
short in terms of participants and time and so fail to turn up side-effects that only appear when a 
larger number of people take the drug over longer periods of time. Although some instances are 
due to such innocent shortcomings of clinical trials, what has been discussed about the 
pharmaceutical industry’s relationship with and influence in the FDA tells of a more insidious 
possibility. On top of its efforts to undermine the FDA’s functionality, the pharmaceutical 
companies themselves are typically the ones funding the clinical trials of their drugs, allowing 
them greater opportunities for subterfuge. They sometimes even have researchers and experiment 
designers conducting the study that are on their payroll (Llamas, 2015). Alternatively, they may 
“hire private physicians or third-party companies called contract research organizations (CROs) 
to run trials for them” many of whom, like the pharmaceutical companies, are generally more 
interested in profits than true scientific research and accuracy (Llamas, 2015)  
The primary alternative to Big Pharma-funded or influenced clinical trials are those done 
by the National Institute of Health (NIH), which is an independent body with no financial 
incentive to skew the results of their data. Unfortunately, the ratio of studies conducted by the 
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NIH and those conducted by pharmaceutical companies is heavily skewed towards the 
pharmaceutical companies, a trend that has been growing and can be directly linked to the 
neoliberally-driven outcome of reducing government oversight of Big Pharma. A story published 
by DrugWatch on the subject of Big Pharma-funded drug trials revealed “. . .a report from John 
Hopkins University showed that the number of clinical trials funded by the pharmaceutical 
industry has increased each year since 2006, while those funded by the NIH decreased. In 2014, 
Big Pharma paid for 6,550 trials, while NIH funded 1,048, according to a study by Stephan 
Ehrhardt and colleagues published in JAMA” (Llamas, 2015)  in which such information was 
simply concealed or withheld by the drug manufacturer in order to push their product to market, 
as turned out to be the case with drugs like Halcion (Associated Press, 1993) and Risperdal 
(Sullivan, 2019).  
In a similar vein, the most infamous and impactful case of misrepresentation came from 
Purdue Pharma’s marketing of OxyContin, in which they grossly misrepresented the addiction 
potential of the drug in as part of an aggressive marketing strategy to encourage doctors to 
prescribe it more broadly than merely to those suffering pain as the result of cancer (Van Zee, 
2009). Rampant overprescribing of painkillers such as OxyContin is considered to be one of the 
major factors of the opioid epidemic in America today. 
Of course, evidence has mounted that the risks were known earlier than they were 
publicly acknowledged and were in fact actively suppressed or downplayed for as long as it was 
possible to do so. Efforts such as this to conceal wrongdoing and prescient knowledge of its 
potential consequences contributes to the undermining of preeminent authorities’ monopoly on 
knowledge.   Per Ulrich Beck, “. . .science’s monopoly on rationality is broken” (1992:29). This 
is to say that the official channels of scientific assessment are no longer the ultimate authority on 
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scientific matters in the eyes of many individuals. The advent and subsequent ubiquity of the 
internet has allowed for dissenting or alternative viewpoints to be more readily discovered and 
disseminated. Aside from dietary supplements versus pharmaceutical drugs, other topics that 
have seen contesting ideas become mainstream and in competition with official scientific 
proclamations are the notion that vaccines cause childhood conditions such as autism, climate 
change is greatly exaggerated or an outright hoax, and that the Earth is flat. Criticism of the 
scientific mainstream is equally present when it comes to the legitimacy of dietary supplements. 
“Several of the supplement users we interviewed seemed somewhat ambivalent about, if not 
skeptical of, scientific assessments of supplements—with a few informants suggesting that 
conventional medicine has its own agenda for negatively evaluating supplements and 
discrediting other healing systems, namely, because of the close ties between the pharmaceutical 
industry and conventional medicine and to reinforce biomedical authority over alternatives”, 
going on to say “They perceived these practitioners to be engaging in ‘boundary work’ that 
entailed defining the ‘‘other’’ in negative terms. Scientific evidence about supplements was 
received with some degree of latitude” (2006:208). 
Nichter and Thompson attribute this sort of thinking to the aforementioned overarching 
phenomenon taking place in society in which science’s ‘monopoly on knowledge production’ is 
called ever more into question as “. . .people are open to the possibility of multiple and 
differential sources of knowledge” due to “lay involvement in the coproduction and evaluation of 
knowledge” (2006:200). As previously highlighted, the Nichter & Thompson interviews also 
discovered that this apprehension did not simply compel supplement users to shun modern 
medicine and accept alternative medicine without question. The risk society element to the big 
picture becomes apparent once again, as those interviewed held suspicions about supplements as 
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well and sought out methods for determining their safety and the veracity of their claims for 
themselves.  
“Most of the supplement users we interviewed struck us as being cautious, 
if not skeptical, consumers of public information—not passive consumers 
accepting information at face value. Informants maintained doubts about both 
product promotional literature and product quality. They came up with their own 
litmus tests for measuring safety and quality such as the ‘Costco test’ or by 
equating cost with safety quality. Few informants rejected biomedicine and most 
thought that ‘amazing breakthroughs are occurring in science all the time’. On the 
other hand, they did not feel that conventional medicine was a panacea, and many 
suspected that some biomedical practitioners and researchers rejected CAM 
[complementary and alternative medicine] modalities, including dietary 
supplements, ‘out of principle, not practice’” (Nichter and Thompson 2006:208). 
 
It is because of this possible boundary work and the lack of confidence in medical 
authorities to be honest with themselves or others that kratom users have taken the onus of 
responsibility of their own health upon themselves rather than looking to established medicine 
for the conditions they utilize kratom for. They have determined through their experiences with 
various drugs and by the personal research they have done online that kratom’s benefits make 
any potential risks from it acceptable and superior to that of whatever substances they used prior, 
despite the oppositional (albeit contentious) statements made by the FDA and DEA. The result of 
this decision making is the reason members of the kratom subreddit faced the DEA’s mandate 
with such angst and frustration. They had settled comfortably on a therapeutic regimen, only for 
a decision that seemed at the time a definitive one to take that treatment of choice away from 
them and thrust them back into assessing the risk of other alternatives. 
THEME 2: FEAR OF REGRESSION/RETURN TO RISK 
“I can honestly say that if kratom gets banned and my doctor is unwilling 
to prescribe me something, I'm not going to have a choice but to start buying 
street oxy by the pallet. I don't want to do this. I'm scared as hell that I'm going to 
get a pill that's got fentanyl or whatever in it and die. Or that I'm going to walk 
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into a sting and go to prison, where I will absolutely without question hang 
myself. Or that my dealer will be some psychotic tweaker and shoot me in the 
throat when he thinks my wallet is a grenade. I've never so much as gotten a 
parking ticket, but if my choice is between feeling like I used to and illicit drugs, 
I'll take the illicit drugs. I have a million reasons to not buy street drugs, but all it 
takes is one very compelling reason to do it” (SpectroSpecter8, 2016). 
 “Broke my 3rd and 4th vertebrae 3 1/2 months ago and stopped taking 
my pain pills after the first month. Switched completely to Kratom. I stopped 
because I was addicted to oxycodone for over 8 years and almost overdosed 2 
times. I didn't want to go back down that road again. Now who knows what's 
going to happen. :( I'm very scared for the future. I will be in pain for the rest of 
my life” (Rhino2366, 2016).  
 
Fear and anxiety are prevalent emotions conveyed throughout many of the posts made 
during this tenuous period in kratom’s legal history. As such, a great deal of the motivation 
behind the political activism undertaken by the members of this forum was driven by the anxiety 
and assumed risks in the future should kratom become illegal. Beck argues the modern risk 
society’s political movements are often fueled by anxiety in contrast to class-driven needs:  
“There are corresponding differences in the basic social situation in which 
people in both societies live and join together, and which moves them, divides 
them or fuses them. The driving force in the class society can be summarized in 
the phrase: I am hungry! The movement set in motion by the risk society, on the 
other hand, is expressed in the statement: I am afraid! The commonality of 
anxiety takes the place of the commonality of need. The type of the risk society 
marks in this sense a social epoch in which solidarity from anxiety arises and 
becomes a political force” (Beck, 49:1992). 
 
It could be argued that in the instance of kratom’s legality, political movement was 
driven both by anxiety and need, as many members of the forum feel kratom’s accessibility is a 
necessity for them to continue to lead productive and pleasant lives. 
“I would just like to say that when I hear the definition of a schedule one 
drug (high potential for abuse/addiction and no medical value), two things come 
to mind. Alcohol and cigarettes. Of course these things will be legal till the end of 
time. I am a recovering alcoholic and drug addict. Kratom has helped me through 
2 years of sobriety. I am afraid of what I may allow to happen to me when it is 
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gone. Guess I should check into a treatment center now or start hitting those 
meetings more often. Either that or I will die drunk on a street corner with a 40 in 
one arm and a needle in the other. Depressing” (momurda971, 2016). 
 
For others, the fears stemming from kratom’s scheduling is two-pronged: not only do 
they not wish to return to pharmaceutical opioids or their former vices, they also simply cannot 
afford to participate in mainstream healthcare.  
“I'm poor, so my only option is to go to a dealer if kratom is banned or to 
buy off the Dark Net or whatever. If I had private insurance or something, I bet I 
could get at least Tramadol, but as it stands it's cheaper and easier for me to get 
them illegally in the mail probably. Even when I got a tooth pulled, they only let 
me get 5 5mg hydrocodone, and barely wanted to do that. They said something 
like ‘they're watching us like crazy so this is it don't call for more’. . .Fuck this 
drug bullshit in our country, it makes you have to turn to illegal shit because 
everything is impossible to get, and now they want to ban kratom too. (nodnizzle, 
2016). 
“The ounce of Kratom I've been using for 6 years doesn't even cost me $5 
a day. If I attempted to substitute with suboxone that would be an additional $40 a 
day. At my income level that means my child suffers. He won't get new sneakers. 
He'll have to eat low quality food. He won't get to go to college. I may even have 
to put him into foster care for six months while I go through protracted 
withdrawal from long term use. And even if I do decide to. . . fuck [over] my child 
and spend his money on treatment the only doctor in my rural area that 
prescribes suboxone charges $2500 a visit. And suboxone sucks. It's too strong. 
It's not a minor buzz like Kratom” (iforgetpasswordsbruh, 2016). 
 (For more quotes pertaining to this theme, see Appendix C). 
 
The debate on whether or not healthcare is a right or privilege and who should be 
responsible for overseeing it has been a hot-button issue for at least twenty years. Costs have 
continued to rise over the decades (Doyle and Amadeo, 2020) leaving many people in desperate 
circumstances. Attempts made to alter this trend have largely been stripped down and lackluster. 
According to David Harvey, “If ‘corporate power steals your personal freedom’ then the promise 
of neoliberalism comes to nothing. . . It is one thing to maintain, for example, that my health-care 
status is my personal choice and responsibility, but quite another when the only way I can satisfy 
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my needs in the market is through paying exorbitant premiums to inefficient, gargantuan, highly 
bureaucratized but also highly profitable insurance companies” (2007:79-80). In neoliberal 
theory it is ascribed that it is up to the individual to look after themselves and their loved ones 
and that if the healthcare market has proven too costly, new competition or new markets 
altogether will spawn to adjust for consumer demands. The dietary supplement industry has 
sought to occupy this niche, and by the same token kratom has been presented to consumers as 
the cheaper, natural alternative to what is being peddled by mainstream healthcare. The previous 
statements provided by kratom users show they are clearly aware of the overarching trends that 
put them in the position they are in and so feel like they are being cornered by the powers that be 
into compromising positions that are unwarranted. 
This also raises the point that more risk is assumed by poorer or lower-class individuals 
than the wealthy and well-off. “. . .[T]he wealthy (in income, power or education) can purchase 
safety and freedom from risk” (Beck, 1992:35). Those that can afford excellent healthcare (and 
by the same token, excellent doctors and surgeons) are theoretically less likely to be mismanaged 
or have their health concerns dismissed. Another issue this raises is that of wealth inequality. 
Wealth inequality has been a disconcerting phenomenon in the United States and abroad, with 
the wealth gap growing to greater and greater disproportion over the years (Kent, Ricketts, and 
Boshara, 2019). This gap will only grow worse at its current trajectory—and is occurring on top 
of the growing cost of healthcare. This means that unless remedied by some measure, healthcare 
and health-related products will grow further and further out of financial reach for the majority 
of the population. 
Kratom users make it abundantly clear that it is their preferred method of treatment above 
all else, having already determined for themselves that either the pharmaceutical alternatives are 
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too risky or expensive in comparison, or that the healthcare system itself is too dysfunctional to 
be of sufficient help. Some admit they will begrudgingly return to being at the mercy of doctors 
and insurance companies to secure medication, while others are steadfast in their determination 
to never need to rely on these gatekeeping forces ever again. They will either attempt to source 
kratom after it has been banned or will brave the risk of buying prescription drugs illegally, all 
for the sake of rejecting a system that they feel is inadequate and counter-productive in treating 
their conditions.   
THEME 3: DISDAIN AND DISTRUST OF REGULATORY AGENCIES AND PHARMACEUTICAL 
INDUSTRY 
 “Anybody who thinks the DEA, FDA, or any number of ABC agencies are 
operating for the benefit of the people needs to have their head examined. They 
don't give a shit about you. They don't give a shit how their decisions effect you. 
They could care less if what they decide is reasonable or what is best. Their whole 
game is to take in money. . .and finding ways to justify their budget increasing 
under the guise of ‘improving or maintaining the ability to enforce the law’” 
(MisanthropicZombie, 2016).  
“It's quite interesting, these events like this ‘opioid awareness’ BS. All the 
pretend concern for those of us ruined by the ‘painkiller epidemic’ they (FDA, 
DEA, Big Pharma) helped create, if not single-handedly. And on the flip-side, the 
DEA's blatant hatred for those of us ruined by ‘the war on drugs’, the ‘druggies’, 
which they also helped to create, single-handedly. Big Pharma gives us the high-
powered opiates/opioids, and also the Narcan to reverse their effect should we 
happen to consume too many. They give us the addiction and ever-so-caringly 
‘treat’ it with their further destructive Subs [suboxone] and 'done [methadone].” 
(ViragoRider4814, 2016). 
“I find it hilarious that ‘science’ is used when convenient. ‘Science’ 
clearly shows that Kratom produces hallucinations, delusions, etc., but somehow 
can't prove that it's medicinally beneficial. Either these scientists conducting this 
‘science’ are only looking for any/all negative side effects, or the DEA is only 
telling half of the story the ‘science’ is showing. Most prescription drugs have a 
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longer list of side effects. Those are totally safe, because ‘science,’ right?” 
(dad_pants, 2016)1.  
 
From the day the DEA announced its intent to ban kratom right up until they announced 
they would refrain from doing so (and ever since), the users of the kratom subreddit were 
convinced that the events set in motion were never about a genuine concern for public health. 
Cynicism about the true motivations abounded, primarily on the notion that the DEA was acting 
both at the behest of the FDA and to drum up a new element to the opioid public health crisis in 
order to increase their funding. In turn, it is surmised that the FDA crusades against kratom at the 
behest of the pharmaceutical industry, who they suspect is greatly entrenched into the functions 
of the agency and has considerable influence. Although statements made during this time period 
are usually emotionally charged, this is not to say that the accusations amount to mere hyperbole. 
Given the ways in which the FDA operates in contemporary history, there is a substantial 
foundation for these assertions.  
Throughout the 1980s, critics of the Food & Drug Administration claimed that the rate at 
which the agency approved prescription drugs was too slow, costing pharmaceutical companies 
money in lost sales time as well as potentially risking the lives of those who could stand to 
benefit from the availability of awaited medicines and medical devices. Under the Reagan 
administration’s guiding neoliberal principles of limited government spending and market 
deregulation, the FDA saw a 30% reduction in their work force as a cost-cutting measure (Anrig, 
2007). Those assigned to head the FDA claimed that budget reductions had improved consumer 
 
1 Reddit user dad_pants is expressing frustration over the FDA’s two-faced assessment of kratom, accepting 
reports of the most adverse reactions to be definitive evidence while discounting or ignoring reports that are endearing to 




protections, arguing that “tight budgets force efficiency as industry cooperation increases”, 
though consumer advocacy groups strongly contested this claim (Molotsky, 1987). 
This mentality soon begot a different way of conceptualizing the nature of the regulator 
and the regulated’s relationship than had been previously employed and signaled what would be 
a turning point in the chain of events that led to the compromised state of the FDA’s drug review 
process. “In a 1982 speech to the drug industry that is now being cited by both supporters and 
critics of the agency, Vice President Bush said, 'I think we've started to see this philosophical 
shift, the end - or the beginning of the end - of this adversarial relationship. Government 
shouldn't be an adversary. It should be a partner’'' (Molotsky, 1987). After ten years of a modest 
back-and-forth between diminishing and augmenting the FDA’s functionality, Congress passed 
the Prescription Drug User Fee Act (PDUFA) in 1992, a law that permitted the FDA to levy user 
fees against pharmaceutical companies submitting new drug applications for review and 
approval. These fees would be used to allow the FDA to hire more drug reviewers and support 
staff; the surface-level benefit to the pharmaceutical industry would be this boost in staff 
allowing the backlog of new drug applications to be cleared and for the process to move more 
swiftly going forward (LaMattina, 2018). 
”Kratom use is taking money from Big Pharma. That's the only thing the 
DEA is concerned with. $$$” (tcsteffens1, 2016).  
(For more quotes pertaining to this theme, see Appendix D) 
In the initial years of the PDUFA’s inception, user fees accounted for about 35% of the 
drug review sector of the FDA’s total budget (Hilzenrath, 2016). As of 2019, user fees now 
account for 75% of that budget (Sullivan, 2019), making the agency more reliant on a symbiotic 
relationship with the pharmaceutical industry than ever before. Following the PDUFA’s passage 
came a deluge of hindrances and consequences for the FDA: “From 1994 to 2007, according to 
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former FDA chief counsel Hutt, the agency's appropriated personnel declined from 9,167 to 
7,856, while its funding increased by only two-thirds of the amount that would have been needed 
to keep up with inflation” (Anrig, 2007). 
Adding further strain is the stipulation that must be met for the PDUFA to get renewed, 
as it is up for congressional review every five years.  
“Before Congress considers renewing it, the FDA must negotiate with 
industry to keep the money coming. That’s what the law demands: ‘negotiations 
with the regulated industry.’ In practice, the FDA has interpreted that to mean 
negotiate over how it spends the money and assesses drugs. The negotiations 
produce recommendations for Congress and an FDA ‘commitment letter’ laying 
out goals for the agency. It’s unclear what would happen to the user fees if the 
FDA and industry didn’t agree on terms” (Hilzenrath, 2016). 
 
All of these stipulations and caveats tying the FDA intimately close to the pharmaceutical 
industry generally indicates that there are numerous areas in which some glad-handing and 
outright corruption would inevitably fester—a prescient point of interest in the context of the 
FDA’s uncharacteristic crusade against kratom. Such stipulations also contributed to the agency 
being not as much of a vigilant protector against ineffective or exceptionally risky drugs as the 
common person may believe, as the constraints to the FDA’s manpower and the nature of its 
funding lead to serious compromises in its approval process. 
In 1993, the approval rate for submitted drugs was just 36%. In 2015, 95% of all drugs 
submitted were approved on their first try (Hilzenrath, 2016). The rate at which the agency 
moves drugs through this approval process also skyrocketed. It took the FDA about 19 months to 
move a ‘novel molecular entity’ (the official terminology for describing new drugs) through the 
approval process in 1993, whereas in 2015 this time had been cut down to 8.5 months 
(Hilzenrath, 2016). As of 2018, this makes the FDA’s drug approval process the fastest amongst 
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any regulatory agency in the world (Chen, 2018). Evidence that the speed and apparent ease in 
which drugs are approved by the FDA is coming at the cost of quality and accuracy in their 
assessments is mounting. 
One study examined the rate at which drugs were pulled from the market or assigned a 
black box warning (a disclaimer that alerts patient and provider of potentially serious or fatal 
side effects associated with the drug) both before and after the passing of the PDUFA and found 
“. . .drugs approved by the FDA after the passage of PDUFA were more likely to be withdrawn 
from the market or receive a black box warning than medications approved prior to its enactment 
(26.7 per 100 drugs vs 21.2 per 100 drugs at up to 16 years of follow-up)” (Gabay, 2018:88).  
The reality of the new demands on shorter processing times was that they simply did not 
allow for proper review. In an interview with the Project on Government Oversight, former FDA 
drug reviewer Ron Kavanagh stated “. . .when he was at the agency from 1998 to 2008, 
PDUFA’s target dates for FDA action left too little time to review drug company submissions, 
which could total 160,000 pages not counting supporting data. Reviewers were told not to worry 
about studying all of the material, Kavanagh said. ‘There’s a lot of things I simply didn’t look 
at,’ Kavanagh said. ‘And even without looking at things I barely made the deadlines’” 
(Hilzenrath, 2016). 
 Although the drug approval process certainly has more hoops to be jumped through to 
reach the market than dietary supplements do, it appears that the contemporary way in which the 
FDA goes about it makes for safeguards that are only modestly more protective in nature. Given 
this, the risk-averse consumer is tasked with determining the validity of the product regardless of 
the avenue they take. The need for individualized risk assessment is not unique to medicinal 
needs nor the healthcare market at large. It is a phenomenon that has touched nearly every aspect 
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of society. The new ‘risk society’ of the modern era has hefted the onus of risk assessment onto 
the individual, as the current dominance of the neoliberal ethos has diminished the state’s role in 
such matters. 
“Politics is said to have migrated from the official arenas—parliament, government, 
political administration—into the gray area of corporatism. The organized power of the interest 
groups is said to produce prefabricated political decisions which others must then defend as their 
own creations” (Beck, 1992:188). The American neoliberal ideology simultaneously being about 
personal liberty and free markets in theory while being restrictive on the former and protectionist 
on the latter in practice begins to have a tangible explanation. When corporate interests pervade 
policy decisions, ‘liberty for me, but not for thee’ is the motto. Industries lobby for leeway on 
matters such as reduced taxes or regulations while angling for directives that help quash 
competing industries or companies that lack the lobbying power they do to fight back, effectively 
rendering their respective markets monopolized or oligarchized. 
All the while, these businesses such as Big Pharma run marketing campaigns that depict 
themselves as altruistic innovators of medicine for the benefit of humanity and regulatory 
industries such as the FDA continue to publicly maintain that they are always at the service of 
and acting in the interest of the general public. While substantially true at one point in time, this 
has diminished significantly in contemporary history.  
“Kratom saved my life. I haven't taken it in 2 weeks. I've abstained way 
easier than heroin and I still have Kratom in my possession. They don't care 
about us. . . It's all about securing the market for subtex, subsolv, Suboxone, 
methadone. . . With Kratom an addict can treat themselves. . .With these other 
options it results in a lifetime of prescriptions and or clinic visits.... Or switching 
on and off with these medications and street drugs as is appropriate. . .I love 
America. I cannot stand the way those with power make it worse and worse. In 
this case we have the blind leading the sick. . .It's not bad enough we have 
hundreds of OD’s [overdoses] a week due to fentanyl.... Now they're going to 
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push some people back in that direction. The whole thing is one step away from a 
silent genocide with profits” (Ibvulpine12345, 2016). 
 
The accusation that the pharmaceutical industry creates the sickness and then sells the 
cure is not new or novel. Per David Harvey, “Technological developments can run amok as 
sectors dedicated solely to technological innovation create new products and new ways of doing 
things that as yet have no market (new pharmaceutical products are produced, for which new 
illnesses are then invented) [emphasis added]” (2007:69). The FDA complacently shepherded 
in all manner of powerful opioids and permitted them to be utilized for a much wider breadth of 
conditions than was sanctioned in the past, then dragged its heels to instate any meaningful 
revisions to its advised prescribing practices even while the signs of an addiction and overdose 
epidemic grew glaringly apparent. All the while pharmaceutical companies began to roll out new 
drugs meant to assuage opioid related side effects, such as Sennekot for opioid-induced 
constipation and Narcan to reverse opioid overdoses. As of 2017, Purdue Pharma has made $37 
billion from Oxycontin (Keefe, 2017), while producing Narcan has become worth $274 million a 
year to the industry (Jaffe, 2019). To wit, “The industrial system profits from the abuses it 
produces, and very nicely, thank you” (Beck, 1992:56). 
Beck also discusses the manner in which the modern risk society has seen what was once 
firmly in the political sphere slip into the purview of scientific, technological and economic 
fields in the name of their modernization (1992). Now industry is more involved than ever with 
the government’s presence in its respective markets, having more definitive say and control of 
public and political matters. The popular sentiment evidenced in the forum passages identifies 
this phenomenon as being the true motivator behind the efforts of government agencies to step in 
on things such as kratom use, being done not in a genuine concern for public health but as the 
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result of the corporate interests seeking intervention in matters they feel are counterproductive to 
their own goals. “If one wished, one might say that the devil of economy must sprinkle himself 
with the holy water of public morality and put on a halo of concern for society and nature” 
(Beck, 1992:186).  
Dissent and disbelief of the authoritative bodies that produce ‘risk definitions’ such as the 
FDA and DEA is according to Beck an expected manifestation in a risk society since the 
monopoly on knowledge no longer belongs to the state or any other major authoritative body. 
The emergence of a risk society also entails a “science, media and information” society (Beck, 
1992:46). As a result, conflicts between the risk definition producers and the consumers of risk 
definitions are virtually inevitable. 
Though at first glance it seems the state has largely been rendered invalid save for when 
it is enforcing the will of ‘corporatocracy’, there is another side to this coin in risk society. In 
what Beck calls ‘the boomerang effect,’ the risks and hazards produced by those who profit from 
them comes back to collect, no matter how wealthy or powerful the individual or organization 
may be. “The formerly ‘latent side effects’ strike back even at the centers of their production. 
The agents of modernization themselves are emphatically caught in the maelstrom of hazards 
that they unleash and profit from” (Beck, 1992:37). For the pharmaceutical industry at large, 
repercussions for releasing drugs for public consumption that failed to be properly scrutinized 
have been extant. “As of November 2016, when ranked by the amount paid in fines and 
settlements since 1995, drug firms took three of the top four spots. . .” (Hilzenrath, 2016). 
Pharmaceutical companies have subsequently paid out tens of billions dollars for things 
including but not limited to “. . . [settling] allegations of hiding dangerous side effects, [and] 
promoting drugs for uses not approved by the FDA. . .” (Hilzenrath, 2016). In the case of Purdue 
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Pharma in particular, these repercussions have now cost the very life of the corporation itself. On 
October 21st 2020 , Purdue plead guilty to three criminal charges, admitted wrongdoing in 
fueling the opioid epidemic, and was ordered to pay $8 billion in various fines and fees as well 
as being forced to dissolve (Isidore, 2020). The Sacklers, the billionaire founding family of 
Purdue was forced to personally pay $3 billion (Balsamo and Mulvihill 2020). 
The righteous indignation towards the FDA, DEA, and pharmaceutical industry that 
comes with being a proponent of kratom arguably stems from feeling as though they have seen 
past the curtain and are wise to the true forces that drive policy decisions like the ones made 
against kratom and the ones that allowed liberal prescribing practices of powerful narcotic 
painkillers to go unhindered. The determination of federal agencies to try and seal off easy 
access to kratom products would hamper people’s ability to continue boycotting prescription 
drugs and the medical system at large, forcing them into a paradigm where they know there are 
better alternatives but are largely powerless to utilize them. Compromising the ability to swear 
off conventional prescription medications in turn jeopardizes the ability to resist the system and 




This research project collected forum posts from Reddit during the time which the 
fight for Kratom’s legality was at its most dire in an effort to explore the themes that 
arose and their relation to Beck’s Risk Society. These narratives demonstrated forms of 
resistance towards the healthcare system as it has manifested in our current risk society. 
In the first theme, “Desire for Treatment Agency and Personal Liberty” was closely 
associated with the Crises of Trust and a loss of Monopoly on Knowledge Production 
elements of risk society as well as the developmental shift from being a passive to an 
active patient in the medical treatment process. The second theme, “Fear of Regression 
and a Return to Risk”, a telltale shift was displayed from class-based to anxiety-based 
needs sparking political action, another trait of risk society. From the third theme, 
“Disdain and Distrust of Regulatory Agencies and Pharmaceutical Industry”, shares the 
risk society trait of the first theme, the loss of monopoly on knowledge. Additionally, it 
demonstrates the realms of science and technology intruding into the political sphere and 
the development of ‘corporatocracy’ corrupting the regulatory and legislative bodies 
meant to keep them in check.  
The narratives of resistance to current healthcare standards starts with the very act 
of using kratom for self-treatment of medical conditions. Users call on the American 
neoliberal ideals of liberty and self-reliance to establish their right to seek medical 
alternatives to their ailments and to be active patients. Though some professed that they 
would resign to falling back under the yoke of doctor supervised prescription drug 
therapies should kratom be banned, others remained adamant that they would continue 
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seeking kratom or other illicit alternatives in order to continue their own health 
management free of the constraints of the medical system. Their determination to break 
away from the ascribed methods of seeking treatment was fueled by the conviction that 
the effort to demonize and prohibit kratom was carried out under the auspices of greed 
and corruption, with the pharmaceutical industry as the proverbial puppet master pulling 
the strings of governmental bodies. 
The resistance that spawned from attempts to ban kratom have their roots in risk society. 
Beck contends that in the economic and technological drive towards modernity, conventional 
notions of what is considered a political matter has grown too small to accommodate the new 
realities of social change. Because of this, ‘non-political’ matters manifest political action 
outside of the political sphere (citizen initiatives, social movements, etc). This new niche is 
described as ‘sub-politics’ (Beck, 1992). Beck elaborates further:  
“The modernization process furnishes the gradually emerging centers and 
fields of action it makes possible for sub-politics with opportunities for extra-
parliamentary monitoring with and against the system. . .the ‘heads’ of the 
political system are confronted by cooperatively organized antagonists. . .citizens 
transform themselves from the loyal addressees of political decrees into political 
participants and attempt to sue for their rights in court against [emphasis the 
author’s] the state, if need be” (1992:194).  
 
Through grassroots organizing in the kratom forum, people were encouraged to call their 
state representatives and the DEA, urging them to put a halt to the kratom ban while urging one 
another to sign petitions and to make donations to the American Kratom Association. Through 
public pressure and lobbying efforts by the AKA, a historic victory was achieved against the 
machinations of government bureaucracy and corporate interests. The forum is what allowed 
individuals from all over the country to share a virtual space in which they could collectivize and 
their personal desires for being in greater control of their treatment, their worries about what 
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would become of them should kratom be banned and their rage towards the government and 
pharmaceutical industry’s interloping into their medical care could coalesce into tangible 
political action. Their individual acts and expressions of resistance were given a vehicle to be 
effective weapons against legislation they did not agree with and felt trampled upon their 
liberties. 
The existence of the kratom subreddit allowed for news and information about the plant 
both in terms of its pharmacology and legal battles to spread more rapidly, which in turn 
promoted evidence of kratom’s safety that contradicted official announcements and allowed for 
swift response whenever kratom’s legality was threatened by any level of government. The 
American Kratom Association also took advantage of this forum by directly addressing the 
kratom community about news regarding such fights, keeping those informed who may not 
receive their newsletters or even knew of their existence prior to joining the subreddit. Since the 
DEA’s kratom ban attempt was thwarted, the progress of ban bills at the state, city and county 
levels have been stymied, with many such bills being halted or overturned. One such example is 
of Tennessee, where in 2017 kratom was initially included in a substance ban bill but was later 
removed from it thanks to lobbying efforts from the AKA and public pressure. Instead, only 
synthetic derivatives of kratom were banned and an age requirement was mandated that required 
a person be aged 21 or older to buy kratom (Autler, 2018). In 2020 Monroe County, Mississippi 
overturned their kratom ban after hearing from advocates (Roberts, 2021). 
The continued success against kratom bans is what is known in risk society as the 
‘amplification effect’, which entails “. . .that the basic rights can be observed successively and 
expanded in a mutually reinforcing way and thus can amplify the ‘resistance power’ of the 
‘basis’ and the ‘subordinate agencies’ against unwanted interventions ‘from above’ (Beck, 
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1992:195). The culmination of this ‘amplification effect’ appears to be coming in the form of the 
Kratom Consumer Protection Act, a bill drafted up by the AKA intended to regulate the kratom 
industry in a manner similar to medical marijuana. AKA spokesman Mac Haddow laid out what 
the bill entails:  
“. . .every kratom distributor has to register with the state that they're 
selling a kratom product. . .they have to submit a lab analysis of the products they 
propose to sell from an independent lab that meets federal requirements. . .the 
products can have no greater than the alkaloid content that shows up in the natural 
plant. . .you have to manufacture it according to good manufacturing standards 
and you can't add any deleterious ingredients to the product — and you have to 
list all the ingredients on the package, so people know what they're getting and 
what the serving size is” (Roberts, 2019). 
 
The bill would also encourage an age restriction for purchasing kratom for anyone under 
the age of 18. The idea behind this bill is that bringing self-imposed regulation to the industry 
will attenuate the health and safety concerns that prompt the creation of ban bills throughout the 
country. So far, Utah, Nevada, Georgia and Arizona have signed the bill into law, with other 
states such as Colorado and Wisconsin currently taking the bill through the legislative process 
(Roberts, 2019). 
Personal and collective resistance concentrated into a sub-political collective proved 
powerful enough to sway decision making within the political arena. It now enjoys the benefits 
of its own momentum, with victories against similar efforts to restrict access to kratom being 
abated. For now, it would seem that kratom users have overcome their trials in the risk society 
and the unique threats to true personal liberty and democratic representation that economic elites 





The findings of this research displays that the roots of the kratom controversy 
reach to far deeper and pervasive issues contributing to America’s development into a 
risk society. Remedying the greater issues that fuel events such as these will be a colossal 
and onerous undertaking requiring a complete cultural shift and revision to the idea of 
what makes the country what it is. Given how deeply entrenched the odious nature of our 
country’s inner workings is, broad-spectrum solutions will take decades to implement and 
take hold. When it comes to our medical and healthcare systems, permitting more 
accessible alternatives to conventional medical treatment such as dietary supplements is a 
way to create a release valve to assuage the pressure growing from our unsustainable 
method of healthcare. Measures must also be taken to properly oversee the dietary 
supplement industry to ensure the therapeutic potential of such substances are not 
confounded by poor manufacturing standards and deceptive labeling.  
Kratom is a substance that holds great potential for a variety of ailments ranging 
from chronic pain to mental illness but is not without risks. Its potential to interact with 
other medications and substances is largely unknown, as are the consequences of long-
term habitual use. Although what has been discerned of its safety profile places it in 
better standing than its typical opiate and opioid counterparts, it is still a potentially 
addictive substance. 
Furthermore, what is currently known about kratom’s safety is entirely in the 
context of the unadulterated plant; extracts and isolated alkaloids may not be as favorable 
to one’s health and might move the needle on kratom from botanical to drug in the eyes 
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of undecided policymakers. If these enhanced products end up having risks comparable 
to traditional opioids, it is in the best interest of kratom for these products not to be sold. 
The possibility for negative health consequences and addictiveness do not automatically 
make kratom ineligible to be a legally available substance. Alcohol, tobacco and other nicotine 
products are still permitted and widely consumed despite their well-established potential for 
addiction and bodily harm. Like these substances, making the public aware of the risks and 
placing an age restriction for purchase would be reasonable and acceptable measures for 
permitting kratom in a legal market. The Kratom Consumer Protection Act would provide ample 
regulatory measures for selling the botanical, as it includes age restrictions and forbids 
adulteration, all while filling in the gaps currently present in the regulation and oversight of the 
dietary supplement market at large.  
LIMITATIONS 
Utilizing Reddit to collect data may prevent this research from being generalizable, as the 
site is known for being home to several resistance movements against ‘the powers that be’. 
Emotions were also running high during the time of these posts which may have overinflated 
people’s true views that they hold when not confronted with such a scenario. The study may 
have also been limited by the lack of available academic data surrounding such a topic. 
Additionally, a bill has recently been introduced by Democrats that contains drug price 
negotiations and other provisions intended to curb the power of the pharmaceutical industry that 






The similarities shared between kratom and medical marijuana opens up a potential 
avenue of research regarding their parallels. Additional research could be done about the DEA’s 
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 APPENDIX A: CODED WORDS, KRATOM AGE DEMOGRAPHICS POLL 
A complete list of coded words and phrases with the number of times they were detected: 
Addiction: 193 
Big Pharma: 123 
Chronic Pain: 106 
DEA: 1436 
FDA: 310 

















APPENDIX B: DESIRE FOR TREATMENT AGENCY AND PERSONAL 
LIBERTY 
“This country needs a revolution! Why dont they ban some of these 
additives whith twenty letter names there putting in our food. We sure dont know 
if thats safe? Or cell phone microwaving our teenagers brains. Were not sure if 
thats safe? Somebody doesnt like drugs period,even if its a plant. Well they 
shouldnt take it than? Its all about political correctness,these days. People need 
to get a fucking life,and start running there own program. Dont worry about what 
other people are doing. If you want to take my kratom so I cant work 
anymore,than come pay my fuckin bills if your so worried about my safety” 
(BuckSteel77, 2016). 
“Yup, my doctor was a nurse practitioner a year ago so I changed to 
another because she did the same shit with anti depressants and ibuprofen or 
whatever. Then the actual doctor I see now did the same fucking thing, even 
though there are records that these things make me worse. No matter where I go, 
as long as there's not a bone sticking out of me they won't do shit about anything 
but waste my time. It's just nonsense, I'm better off looking up shit online and just 
ordering shit to help myself. They think of poor people as annoying bugs even 
though they still get paid by our state insurance. I remember having a real doctor 
when I could afford it. They would bend over backwards to make sure I was okay, 
and it was great. Now I feel like I'm an asshole for even going and wasting their 
time” (nodnizzle, 2016). 
“Doctors have and will always pick and choose what is valid and what is 
not, and also when it's appropriate to prescribe and when it's not. Really, getting 
pain meds has nothing to do with how bad your condition is or if it's verifiable. 
It's all a roll of a dice, depending on which clinic you go to and what doctor you 
speak to. There is no rhyme and reason to it. Really, it's no wonder people switch 
to kratom. You order it, and then you get it in the mail, and that's that. None of 
these mind games these doctors play, bouncing you from clinic to clinic and yet 
still not giving you what you need. I mean, I got years of therapy and psychiatric 
visits under my belt, with my depression and anxiety documented. I've tried so 
much shit that has screwed up my head and failed miserably at what it was 
supposedly intended to do, and yet I can't even get a measly prescription for 10 
attivans. It just don't make sense” (kfctw_x, 2016). 
“It's not that the DEA may be unaware, these people are just naturally 
ignorant corrupt morons. They left marijuana as schedule 1 this month too, 
claiming marijuana has ‘no medicinal value’. This isn't a Kratom issue, this is a 
‘corruption big brother 1984 issue’ where THEY tell us what to take. 
Pharmaceuticals = legal but deadly. Kratom = not deadly but let's make it illegal. 
Same with marijuana in place of Kratom. It's pathetic that we've allowed our 




“This is why doctors need to be eliminated as the gate keeper for drugs. 
Problems like this will always happen. What needs to happen is people need to 
take control. Sure, the government tells us what to do but only because we want it 
to. If the people wised up to this nonsense then we could buy any drug OTC we 
want, with the advise of a doctor, if we so choose. Sure, people would die, but ask 
yourself. Would it change YOUR behavior? Would you go and buy random blood 
pressure medicine or cancer medicine for no reason? Or would you go to the 
doctor and get diagnosed and then buy it? But if you have a terrible headache, 
why not go get 10mg of morphine, or 5grams of kratom, or whatever? Sure, 
people will hurt themselves sometimes, but that is a problem of education. It 
worked perfectly fine when it was like this in the 1900s. The problem then was 
snake oil. The FDA could ensure that things were legitimately what they were and 
did what they claimed to do today and that is all that's needed” 
(Throwawayhelper420, 2016). 
“It IS our responsibility to engage in civil disobedience. Complacency and 
laziness is the dystopian society we had hoped to avoid in the modern world. I still 
care about my freedom. I DON'T THINK somebody else knows how I ought to live 
my one life better than I do. I am no fool” (Canibeyourdoctor, 2016). 
“Just fucking ban water while you're at it. Too much of that can kill you 
too. I'm sick of these people thinking they have the RIGHT to dictate what the rest 
of us can and can't injest down to the micro level. This system is archaic and the 
people who run it are fucked in the head” (Craaycraig, 2016). 
“. . .I said this is America! I have the right to ingest whatever the fuck I 
want (I didn't say fuck) but then I said ok the government says they are banning 
eye glasses because its a safety hazard if you break them-would you say ok I will 
give it up because the government says so?? Um no he says-I can't see without my 
glasses. Ok I said. I can't function without my herbs. I have tried other options. 
they didn't work. This works. What's the problem??” (foxxy1974, 2016) 
“I have a huge fear that big pharma is desperately trying to take 
advantage of this 'miracle' plant, Kratom. If they succeed then they will end up 
making insanely addictive pain medications. Kratom does not cause any serious 
health risks as far as I am concerned, ime [in my experience] anyways. I have 
been using for chronic debilitating pain for a decade now and it has been a 
blessing from God for me, I try to avoid any actual opiates or opioids, and I am 
very proud to say that I haven't touched those in over 5 years now. . .It just blows 
my mind, it is sad living in a 'free country' yet we aren't even ‘allowed’ to 
purchase and use healthy, natural herbs. As long as it's safe (which it is), and 
you're not putting others in danger (which hasn't happened as far as I know), we 
definitely need rules and regulations for pharmaceuticals but kratom?! Seriously? 
there is much bigger at play with this thing than most realize” (Username 
Deleted, 2016). 
“. . .You must be approved by a doctor who will arbitrarily decide what 
you need to take and how much. Each doctor you say may have a different 
opinion but hey, they have medical degrees so obviously they know more about 
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your situation than you, the person in pain, does. Perfect example of this. I was 
having panic attacks and this doctor put me on Effexor XR, one of the most 
powerful SNRIs on the market. This medication has horrible withdrawals, enough 
to keep you in bed for over a week with head spinning and passing out type shit. 
He could have easily gave me something light to start off with, like gabapentin, or 
pregbalin, baclofen, etc, but no, let's start off with the strongest medication out 
there. So here I am on year 3 of effexor ‘addiction’ when I don't want to take this 
shit because it gives me massive mood swings and if I don't take it I have 
incredibly bad anxiety and can't focus on anything for 1 second without getting 
dizzy. Our system is beyond broken, doctors are not as knowledge about 
medications as one would think” (DerkBerk, 2016). 
“Why can't we make our own decisions about our body. Why do we 
always have to get doctors involved. The fact that we have a rigged healthcare 
system and the the dea is concerned with 'self medicating' is troublesome. Who 
are they protecting by fighting a war on self medication?” (kamelizann, 2016). 
“Unfortunately, Americans have been in somewhat of a slumber the last 
20 years...perhaps due to the fog and haze that prescriptive medications induce or 
maybe because we have subscribed to the notion that our government really is 
protecting our best interests... However, we ALLOWED our constitutional/human 
rights to be compromised, minimized in lieu of of the government's averments that 
their call to action when passing legislation is for the benefit of public safety. 
And, perhaps, in its infancy, laws passed to protect the public was innocent 
enough. However, we are now suffering as victims of these same laws, laws that 
are being exploited in ways the initial proposals were not intended, 
circumnavigated to enable legal corruption as our elected and appointed public 
servants, zealously, capitalize on these laws for private and personal gain. It's 
time to take back our country. We can no longer sit back and watch the 
government ban 3000 natural supplements, no longer accept legalized 'stop and 
identify' maneuvers by law enforcement that hinder and compromise our rights as 
citizens of the US, a conceptually free society. The ignominy these public servants 
have exerted upon Americans in pursuit of individual incentives has become 
clearly obvious. Whatever becomes of Kratom's legal status, may this be a lesson 
to us--legislation needs correction, and proactive, preventive measures need to be 
enforced by the people of this country, to stop this madness. ‘When injustice 
becomes law, resistance becomes duty.’ --Thomas Jefferson” (Gummybears-
Lollipops, 2016). 
"’But we are concerned with the public self-medicating itself’ When was it 
decided it was the governments job to manage my medication, and supplements? 
I'm a grown ass man who is smart enough to know the risks involved with putting 
ANYTHING in my body. Whether that be bleach, or a harmless plant” (Mudsnail, 
2016). 
“Its really crazy bc many Kratom users have been through the circuitous 
route of prescription medication. Many prescriptive medications either do not 
work well or possess considerable side effects that minimize functionality and 
quality of life. What is the recourse other than self-medicating for this group of 
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people? And what exactly is so unethical or immoral or illegal to CHOOSE to 
self-medicate? It's pathetic that a non-controlled prescriptive medication such as 
Requip or Mirapex, indicated to treat Restless Leg Syndrome, can cause sudden 
narcolepsy during daytime--meaning you can fall asleep abruptly and knowingly 
while driving or at work. Joke! And this isn't even a medication that is scheduled! 
Awesome, trying to legitimately treat s bad bout of RLS during nighttime and I 
could feasibly put my children at risk as I'm driving them to football practice. 
Here's the deal with the FDA...they are required to list every single side effect 
that is reported by patients that contact quality control--regardless if they have 
any evidence to support their claims and these adverse events are updated in the 
drug's package insert. The FDA is doing the same thing with Kratom, they are 
going to tally up the adverse events associated with Kratom based upon user 
testimony. This is why you see their claims of: psychosis, hallucinations, and so 
forth. This is their template of science. Kratom's safety profile in terms of 
mortality is pristine. They got nothing there. They can claim that Kratom's 
efficacy compared to a narcotic is statistically significant, however, it won't kill 
you unlike a true opiate, at least at doses we consider as normal. What they may 
do, as they have with antidepressants in clinical trials to demonstrate safety is to 
outrageously overdose and see what happens. If all fails, they will resort to the 
side effects that the public reports during the public comment period. The FDA is 
very crafty at manipulating outcomes. But I'm sure the AKAs legal team has the 
foresight and the ammunition to hopefully overcome these tactics. Again, keeping 
Kratom legal and accessible is a small issue of a much bigger problem. The 
government is controlling our ability to seek alternative therapeutic relief by 
making nature illegal and that is plainly unconstitutional” (Gummybears-
Lollipops, 2016). 
“Why are you [DEA head Melvin Patterson] concerned with the public 
self medicating....we own ourselves motherfuckers. You aren't my mother fucking 
parents. You don't and can't know what's right for me or anyone else in the 
godamn country. Fuck off with that shit!” (leffingsuck, 2016) 
“Since the FDA is already inciting that Kratom users are self-medicating, 
they already perceive Kratom as a drug. And self-medicating equates to abuse, 
that dirty, seedy word that gains public approval and congressional support. The 
FDA will lose safety and efficacy arguments with Kratom--the safety profile is 
close to pristine, and subjective, testimonials lacking evidentiary scope will aid in 
their efforts to feverishly tally those awful side effects--but they plan on winning 
this based upon abuse. Their deflection from Kratoms safety will be abuse and 
perhaps the negative side effects reported that the FDA is required by law to 
disclose. . .Personally, I think it's absurdity, but this has become a legal and 
politicized battle that needs to be won to set a future precedent that citizens will 
be willing to fight to preserve their rights and to lessen the reins that the 
government had upon the people” (Gummybears_Lollipops, 2016). 
“Essentially, it needs to be treated like a methadone prescription and not 
politicized like marijuana. No. Not everyone uses it that way! Most people use it 
for pain, not addiction. Also, people like me use it to help with mental health 
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issues. If it was treated like a methadone prescription as you said, it will never be 
prescribed. No one can patent it. It will be as if it were banned - impossible to get. 
Unacceptable. We can regulate without making it a prescription only plant! Why 
shouldn't ‘any idiot’ be able to buy it if it is safe anyway? How do you determine 
who an ‘idiot’ is? Kratom is regulated as a natural health supplement in Canada 
and that's what it should be here” (carpet_munch, 2016). 
“OK, lets ban alcohol. Lets ban tobacco. Lets ban coffee. Lets ban soft 
drinks, cheeseburgers, sex, and loud music. Or... lets let adults make decisions as 
long as it doesn't hurt anybody else. Especially when it is something as 
ridiculously benign as kratom” (sonicode, 2016). 
“Perfectly stated...Dear overly intrusive government agencies, biased 
medical community, corrupt multi-national pharmaceutical institutions, et al., 
please stay out of my personal dietary and recreational bodily intake practices. I 
am harming no one, and only benefitting personally from what I decide to put into 
my body. Please stop your war against the good, tax paying citizens of this 
country. That is all” (mushroomsmoke, 2016). 
“Yup, us Americans have been so brainwashed into thinking nobody can 
make the decision of what's best to put in their own body. They literally claim 
suboxone/methadone are legit medicines with NO withdrawal yet heroin is seen 




FEAR OF REGRESSION/RETURN TO RISK 
“I injured my spine and received surgery. The surgery was a trade off. 
Immediate relief of relentless pain and increased mobility for a lifetime of 
treatable pain. Unfortunately, treatable pain meant taking prescription narcotics. 
The narcotics dulled the pain, but did nothing for the inflammation. Which meant 
there would be weeks where I wouldn't leave the house because of how painful it 
was to move. It was still an improvement from life before surgery though. But, 
then came the side effects of the narcotics. A constant pain in my abdomen 
eventually landed me in a gastrointestinal doctor's exam room. After some tests 
he determined there were problems with my liver and stomach. There were also 
some very embarrassing issues with my colon due to the hardening of stool 
caused by the narcotics. I had to immediately stop taking all pain medications and 
was placed on a strict diet of broth and water for 3 months until my digestive tract 
returned to normal. The pain with narcotics was tough, without the narcotics it 
was unbearable. I searched the internet for anything that would help. After trying 
a few things I came across kratom. Nothing was working and I didn't expect 
kratom to work either. But, it did wonders that still shocks me to this day. It acts 
as an anti inflammatory and a pain reducer. It is also very easy on my digestive 
tract. I still have pain, but it's a manageable pain now. I can leave the house and 
have returned to a somewhat normal lifestyle. No narcotics, no addiction, no side 
effects. The government, the citizens, and the economy also saw a boost from my 
use of kratom. I was able to get off of disability and go back to work. People 
sometimes believe those on disability are lazy. I actually called the SSA and told 
them to stop my benefits. That's how thrilled I was to get back to normal. I owe 
that all to kratom. Now what though? What happens if it becomes illegal? I go 
back to prescription narcotics, the pain and inflammation come back, the internal 
digestive issues come back, and I'm afraid I will be filing for disability again 
while I'm stuck living my life in bed with constant pain. I wish the DEA actually 
cared about Americans more than they care about pharmaceutical corporations” 
(TheDEAHatesPlants, 2016) 
“Kratom saved my life. I was addicted to methadone for over a decade. I 
was able to quit with the help of Kratom. If this ban does go through, then it looks 
like I'll be updating my Tor Browser and getting my Bitcoin account in order. I 
hate to be treated like a criminal but I refuse to let the DEA destroy my life” 
(Username Deleted, 2016). 
“I would just like to say that when I hear the definition of a schedule one 
drug (high potential for abuse/addiction and no medical value), two things come 
to mind. Alcohol and cigarettes. Of course these things will be legal till the end of 
time. I am a recovering alcoholic and drug addict. Kratom has helped me through 
2 years of sobriety. I am afraid of what I may allow to happen to me when it is 
gone. Guess I should check into a treatment center now or start hitting those 
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meetings more often. Either that or I will die drunk on a street corner with a 40 in 
one arm and a needle in the other. Depressing” (momurda97). 
“I was just thinking about how crazy the ‘imminent public health crisis’ 
part of the kratom scheduling really is. It has always been ridiculous due to how 
mild and non-harmful it is, but hearing all of these testaments of how many 
people were able to finally get off of harmful pain medications and worse with the 
help of kratom has made me realize that the DEA truly has it backwards. How? 
With the great number of people who used kratom to stop using narcotic pain pills 
now having less than ONE MONTH to make an appointment with a healthcare 
provider to get back on the harmful pain medications, how many do you think will 
end up on a waiting list that lasts until long after kratom is scheduled? Then, what 
do they do? No kratom, because that is then just as illegal as heroin, yet even 
more difficult to get. How many people are going to switch to something even 
worse than those harmful pain prescriptions they so successfully were able to 
reduce the use of or totally stop using due to kratom? Scheduling Kratom will 
cause an imminent public health crisis, and the DEA is going to destroy the lives 
of people that people worked so hard to get off of harmful, life-destroying 
narcotic prescriptions...SAD!” (Username Deleted, 2016). 
“This is so ridiculous. I was seeing a pain management doctor addicted to 
benzos, morphine, oxycodone from a car accident. I could not work kratom has 
helped me stay off pain medication. I have also taken time away from kratom I 
had no issues other than the return of my pain. I guess when the DEA and 
pharmaceutical companies can't make money off of drugs they ban them. Because 
let's be honest if they had concern about calls to poison control centers they 
would ban Tylenol too. I guess I'll have to go back on some type of pain 
medication or stock up. The DEA are a bunch of scumbags” (Paul8211, 2016). 
“Heh Kratom saved my life and now the DEA wants to kill it. Nice. I'll be 
sure to address my goodbye world letter to all of the top executives at the DEA 
and congress who were spearheading this decision. (This coming from someone 
who has never been in jail, never smoked or done drugs or even pot and never 
wants to). Kratom took my chronic pain and depression and anxiety and took it 
away and made me feel like a normal person. Now the dea wants me to kill 
myself. Letters written, messages posted, but if it goes thru with the ban, I 
probably will just end it. Don't feel bad for me. It is what it is. Tired of the chronic 
pain game and don't wanna be a slave to the pharmaceutical companies and my 
doctors willingness to write me prescriptions. I truly feel the DEA is evil at this 
point along with all of congress R and D alike” (Iamkratomplzlisten, 2016). 
“I AGREE its literally backwards , did we not lean anything from any type 
of past prohibition ?? i guess not at least they should allow it and control it and 
the sale of it like they do with every other imported good in america , kind of 
weird right well ill be around to supply everyone until the end of the month ** 
DirectFromIndo.com ***then i will have a list of new things for sale that are 
alternatives keep an open mind , kratom was an alternative for something 
(painmeds mostly) and that worked out very well , while it lasted too ! so maybe 
kratoms will be a great thing too , if it aint broke dont fix it , unless they make it 
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illegal and supress us , then its contradicting to what we are trying to do , find a 
healthy legal way to us manage in our life” (AnthonyBeee, 2016). 
“DEA doesn't know the difference between drug dependence and drug 
addiction.. a 30 day supply of pain pills lasted me 2 or 3 days, a 30 day supply of 
kratom will last, uh, 30 days. I don't want to go back to the life I had 4 years ago 
before I found kratom... I'm calling my Congresswoman Monday, and I encourage 
everyone else to do the same” (twentykillerhurts, 2016). 
“. . . I will continue to use Kratom. I will not stop. Fuck the DEA. I'm 
really not worried about supply because if there is demand for something then 
someone will find a way to supply it. My biggest concern however, is the price 
after the ban. I have a feeling that it will be through the roof. Maybe after a while 
on the black market the price of Kratom will drop and level out somewhat” 
(Danielcmk3, 2016). 
“. . .For people like me (ex painkiller addict, switched to kratom for price 
and health) with no money, it means a lot to see you guys stepping up. I have no 
kratom now, and it's been rough trying to quit. I sincerely hope things get 
reversed so life can go on. At this rate, I'm in big trouble. I don't want to go back 
to methadone. That stuff has so many side effects, it's basically not worth it for 
me” (CedarCabPark, 2016). 
“By simply doing this the DEA has labeled this a dangerous drug in the 
minds of anyone who doesn't know, so now we're addicts. It's hilarious because 
we are actually the opposite. We are actively trying not to take narcotics. What a 
ridiculous country we live in” (Rygar82, 2016). 
“I dislike that my husband takes Kratom, merely bc it's one of his 4 habits 
that we pay for and bc I hate seeing green powder everywhere, however; I'm 
totally terrified for it to become illegal. When we first got together he was trying 
to get out of years of pill addiction. He got out of it, had a few slips, and then 
picked up a DXM habit. He got off of that and would drink. Not alcoholic, always 
drunk. But the man would knock back some shots once the kids were in bed. He 
tried Kratom on a whim when he was trying to quit DXM and obviously liked it. It 
hasn't even been a year since he started taking it and he doesn't even drink 
anymore. We've had the same half-bottle of Kraken [rum] on the counter for 
about 4+ months now bc Kratom makes those desires just nonexistent. Why 
people can't see this is a literal positive life changing substance I simply don't 
understand” (lexieesmith, 2016). 
“Seriously! I actually teared up a little thinking about this the other day. 
Very rarely in history does the DEA ever back down from a decision. I will 
remember for the rest of my life the ominous dread I felt when I saw the first post 
on r/kratom saying that it was going to be illegal. I remember reading some posts 
going like, ‘The DEA is going to get a nice little footnote in my suicide note,’ and 
honestly I almost felt the same way. It felt so hopeless back then, but then we 
actually started winning some battles. I hope that the people that fought back on 
kratom don't just stop when it becomes legal. We have shown that we can do a lot 
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once we unite. Hopefully we can come together to disband the corruption that is 
the DEA. It needs to be cut off like the parasite it is on society” (drazzy92, 2016). 
“I use kratom medicinally for anxiety, concentration difficulties, and IBS. 
It is significantly more effective than any pharmaceutical for my purposes, and I 
know that many others have had the same experience. If this is outlawed, the only 
places we will have to turn to (narcotics or prescription cocktails) are so much 
more dangerous” (Username Deleted, 2016). 
“This is a great great help and I really appreciate you putting so much 
time into writing this out for us. I really hope you will be able to continue putting 
your time into this very valuable cause. Kratom saved my life as well. I found 
kratom in 2010 and was able to kick an evil pain pill problem that all stemmed 
from permanent injuries in a motorcycle accident. I did however already move 
out of the USA because I feared kratom would be banned. So luckily I can still 
legally use kratom except with the times I come back to the USA. This is a 
horrible horrible thing they are trying to do. I estimate at least 1000 overdoses 
and deaths within a week if this bill is passed. The craziest part of it is their 
outright lie about why they feel the need to ban it. They claim they need more time 
to study its effects but processing it as a schedule one eliminates the legality of 
clinical studies. We have been conducting clinical studies in the University of 
Missouri I believe already and have so much scientific evidence already that 
kratom is a great herb. I have used kratom since 2010 literally on an hourly basis 
with zero side effects. I have so many bolts in my body I can't walk without it and 
refuse to go back on big pharma pain killers that previously were destroying my 
life” (higherdistro, 2016). 
“This really kills me... I have been a heavy addict of prescribed pain 
medications for more than 5 years now. I have struggled with trying to get off of 
it, hitting the Withdrawals and crawling back to them because I cannot be 
functional while I am withdrawing. I recently discovered Kratom, and haven't 
even so much as had a craving for any of my prescribed medications. This really 
has been a life changing plant for me and it scares me that it's going to be taken 
away from me. I really don't wan to relapse... again” (VoxVirtus, 2016). 
“Well, here goes the past three pill-free years down the toilet. I know 
people will say ‘Well, just don't get back on pills, ya coconut.’ but I know me. I 
have to have something. I've been like this my entire life, and I finally got to the 
point where only kratom was that something. I know they have read the success 
stories from kratom. You can't do research on kratom without stumbling across 
some success stories. But that doesn't matter to them. They get to choose what I 
can and can't put in my body. They don't care if I get high or not, as long as it's 
from one of their ‘approved’ drugs. I knew something was up when the CDC 
launched their little campaign not long ago. I knew someone had to benefit from a 
bullshit study like that. I guess I've actually had a sense of impending doom about 
kratom since I replaced that first pill with a scoop. It's a bad day for us that are 
trying to give ourselves a better life” (ViolentHallucination, 2016). 
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“Sigh... i am literally scared. I have horrid back pain including numb 
circles all around my left shoulder blade and spine. I work 58 hours a week... this 
is literally what gets me thru my day without pain.... idk what to do... i can get the 
pain killing effect from about 3.5 gram doses.... its not like i abuse it, i dont even 
do other drugs... i refuse to put opiods into my body, because ive watched people 
destroy themselves with it... sigh. Any advice... its pretty much illegal there issnt 
anything to change that.. is there something else just as effective...? Any advice 
helps...” (grantking2256, 2016). 
“Kratom has been a godsend for my anxiety, depression and tool to stay 
away from the deadly amount of booze I was drinking (at least a bottle a day). I 
haven't had a drink since I found kratom almost a year ago. I will taper down and 
use kava as my crutch now. I came close to losing everything from my job, to my 
house, to my family and more and i think it would have been way harder for me to 
make it this far without kratom. I feel sorry for those who have it even worse than 
me” (alfalfamale81, 2016). 
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APPENDIX D: DISDAIN AND DISTRUST OF REGULATORY AGENCIES AND 
PHARMACEUTICAL INDUSTRY 
“This law isn't worth the paper it's printed on. The problem with this 
situation is that most disenfranchised groups in impoverished areas don't have 
access to the good health care that most if not all of their Canadian and 
European counterparts do. Thus, they must self medicate. However, this is made 
more difficult when politicians create these opposition-oriented laws. . .This may 
inherently cause problems in the future when more of the previously mentioned 
under-privleged [sic] are inducted into the justice system. However, cannabis and 
related drugs have also been a boon for the robber-barons occupying the courts, 
and a serious setback for not only those in the lowest castes, but even all the way 
up to the upper-middle class. I mean, it's not rocket science. Anybody who wants 
kratom to be illegal needs to come and catch these hands [fight me]” 
(BIGMANSCOOBS, 2016). 
“Unfortunately the DEA gets funding to fight the drugs that are banned. 
The bigger the heroin and fentanyl epidemic, the more funding they will receive to 
fight the battle against the drug cartels” (chilrum, 2016) 
“It's worth noting that as all of this is going on, there is a very very large 
pharmaceutical company who have synthesized some of the alkaloids in Kratom 
and are in the process of making it into a ‘new drug’ called PZM21. Ban 
something that's made by nature, synthesize its ingredients, potentate it x1000 and 
make it deadly to users whilst earning massive profits in the process. 'Merica” 
(IWillNotBow123, 2016). 
“No one who works for the DEA would have a job without us. They are 
supposed to keep us safe. That's their whole function. to keep US safe. You and 
me. They are not supposed to be the pharma complex's personal army. They are a 
function of the Government. Our government. The one we are PAYING for with 
our tax dollars, the one we elect representatives to express OUR views in” 
(Username Deleted, 2016). 
“Big Brother is always looking out for your best interest! Because we're 
not responsible adults with free will or anything” (Shroom_Cat, 2016). 
“The government is simply trying to ban These RC's [research chemicals]  
because in my opinion they attempt to ban every recreational drug they can 
besides caffeine, nicotine, and alcohol, while pharmaceuticals become scheduled 
prescription only drugs” (EverSpinningSpiral, 2016).  
“Politicians ≠ scientists. Through a generation of political apathy and 
being disengaged in the political process, Gen X, Y, and millennials have allowed 
these idiotic politicians who know nothing about science, technology, or anything 
beyond being career politicians to get into office. This is why we are slowly 
turning into a plutocratic oligarchy of big corporations controlling the interests 
 
 82 
of the people. And we have no one to blame but ourselves for the mess we're in. 
WE HAVE THE RIGHT TO PUT INTO OUR BODIES WHAT WE WANT AS 
LONG AS IT DOESN'T HURT OR INFRINGE ON THE RIGHTS OF ANYONE 
ELSE But our nanny state government doesn't see it that way. They believe the 
drug war is a war about restricting access to drugs under the assumption that 
reducing access to drugs will make people quit using them. In fact, at this point, I 
don't even believe that is true and I don't believe they believe it themselves. They 
want to use the powers of the DEA to control foreign governments and domestic 
dissidents, since they know many free spirited people with their own minds will 
most likely experiment with drugs. Not only that, they want to continue the control 
of the prison industrial complex” (Starscream777, 2016). 
“Every word that comes out of these stupid fucks' mouths just really 
grinds my gears. The height of arrogance! I will never let this issue go as long as 
they don't go through the correct scheduling process. I will be a life long 
detractor of the DEA (and I'm still gonna take Kratom). Fuck this irrelevant 
organization, period” (Lawofnot2but1, 2016). 
“They [DEA] are protecting Big Pharma. The ‘protecting us’ thing is the 
most unbelievable aspect of this whole absurdity” (Aldo3927, 2016). 
“The DEA must be short on revenue. Time to add something else to seize 
and fine people for. There is no logical reason for this. These DEA people know 
nothing about the stuff, clearly” (thedisintegrator, 2016). 
“If kratom is banned and we turn back to harder drugs, I fully believe we 
are playing right into the DEA's hand. I think that is a major motivator for the 
ban: keeping addict$ on hard drugs. They know if a ban occurs, kratom will 
largely stop being available. But hard drugs and prescription meds will always be 
around and those alternatives are money makers for the pharmaceutical industry, 
the prison system, local law enforcement agencies, rehabilitation companies, etc; 
the list goes on. I bet the methadone & suboxone clinics in the US will see a big 
boost just from ex-kratom users alone. It's sad. We can control our own lives! =)" 
(Aldo3927, 2016). 
“How do these assholes in the DEA still have a job? Why don't we come 
together and get the head cocksucker who's trying to ban kratom fired from his 
job? That should send a message to the corrupt, anti-American pieces of shit in 
Washignton DC who bend to the wills of their corporate masters vs bending to the 
will of the American people (as a whole, not individually). Why does the head of 
the DEA hate America so much for?” (Fuherincarnate, 2016). 
“This ban smacks of pharma influence to me. There is just not enough 
evidence to justify a schedule 1 label, but if big pharma is making synthetic 
opiods from Kratom alkaloids, suddenly a whole new meaning to this bs 
emerges” (uhHuh_uhHuh, 2016). 
“The entire population self medicates with aspirin, ibuprofen, 
acetaminophen, caffeine, alcohol, anti-histamines, laxatives, herbs, fruits and so 
forth. So, WHAT'S THIS BS ABOUT SELF MEDICATING???? Is it only a 
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problem when it's kratom, or some other natural substance, that big pharma 
wants to modify and present as a prescription drug? This baloney has nothing to 
do with safety or protecting the public” (time_has_come_today, 2016). 
“How can you not see what Big Pharma has to do with this? They are 
developing drugs based on kratom alkaloids, therefore they do not want the 
cheap, raw form of the drug to be so readily available to the public. They also 
want to stop the thousands of people who are already using this as an alternative 
to the more dangerous and more expensive prescription opiods that are currently 
available. We are hurting their current and future bottom lines” (Rob3755, 
2016). 
“As a vaper of many years, seeing what the FDA did to shit all over the 
budding ecigarette industry makes me fear them. While I suppose that the global 
and even national user base of nicotine products is many times larger than that of 
Kratom, I still see the $ signs they are going to inevitably grab for. I hope my 
analysis isn't skewed by that, but financially they, along with their power brokers, 
Big Pharma, have a massive incentive to bury Kratom forever. I'm also a former 
opiate addict who managed to get free from the snare that they helped create. 
Maybe my perspective is pessimistic, but to a certain extent I think they want 
people addicted and suffering, so they can get them on suboxone for years and 
years. I managed to un-bind myself from 6 years of Sub, but it was brutal as fuck. 
You really can't make money from patentable forms of mitragynine. Much like 
they cannot patent cannabinoid compounds” (Username Deleted, 2016). 
“I think what it boils down to is money. They've seen kratom use go up 
year after year. Now they realize how many people actually use it. And since they 
see it as people self medicating they can't make money off that like all the deadly 
drugs they approved. Just like they stepped in with all the vaping stuff. Now 
they're making money off all that by placing their approval on it and making 
distributors pay money to them. Now they're stepping in here. Either way it goes 
they're gonna start making money from it. Best case scenario it won't be 
scheduled. But they won't just leave it as it is. They'll make all these conditions 
and have taxes on it and make vendors pay for all this extra stuff. I'm speaking 
about the FDA stepping in” (Mikeukblue, 2016). 
“I think we all know the real problem here.. The big pharma companies 
that make billions on pain killers and depression meds need to ban kratom. I am 
completely in favor of petitions but after seeing this shit I'm almost certain we 
have no chance clearly someone made a back room deal or lobbyists paid the 
right people tons of money I seriously don't understand how this isn't up to voters 
and a state by state basis what the fuck government. Then they can pay certain 
large media establishments to write horror stories of how bad it is. Fuck this 
mess” (jackets19, 2016). 
“I'm so sad about this, I just seen this last night ...kratom got me off 
alcohol (which I was having trouble with the law and drinking too much 
before)...now I don't drink and just take this plant for the last 2 years to help with 
anxiety and my quality of life has went up so much. I don't understand how they 
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can do this or why. It's just cause they can't make money off it the way they want. 
I wish they would just tax it, I don't mind paying a tax like alcohol and cigarettes 
just don't take it away. I signed petition but I don't think there is really anything 
we can do. I'll write letters or whatever too but I actually cried last night when I 
saw this. I can't stand our government anymore, I'm sorry but it's the truth. I don't 
see how it's legal to just ban and make laws without the people voting. They can 
use their reach and make anything illegal and put people in jail for whatever they 
want without having to vote on it just cause they don't like it. Making up bs about 
this plant and listening to the rich drug companies over the people. This isn't a 
democracy anymore, the people don't want this, big pharma wants this and 
probably paid someone off to come up with the bs” (MaggiezSoPimp, 2016). 
   “The US sucks. Our Gov is corrupt as hell and does deplorable things under the 
guise of trying to legislate morality. This country is what the early settlers were escaping. 
America is officially nothing more than a corporate whore who sucks the life out of it's 
people for $. Doing drugs is not a crime, millions of people take tylenol every fucking day, 
not a crime, still a drug. I hope that this doesn't go through. America seems to like to make 
it's money off of imprisoning people, bullshit taxes on everything, sucking corporate dicks 
and hostile takeover of other countries with resources in the name of democracy. I tend to 
be a realist and am 99.999% certain that our shit ass government and the DEA will not 
‘hear the people’. Kratom inevitably has put a dent into pharma sales. Since the US is the 
bitch of pharma, they will retaliate. Maybe all kratom ‘addicts’ can go to their doctor to 
get hooked on a ‘safe’ alternative like Fentanyl or Opana or Oxys. So fuck you DEA, you 
pieces of trash, the war on drugs is a civil war on your own people and no one wins. Fuck 
congress too while we're at it. Make America America again. (Not Trumps way). While I 
agree protest and standing up is a good theory, until the people militarize themselves, 
there will never be change in this country until the people get there own military. 
Seriously. It's so far fucked up that there is no chance for middle ground, it has to 
completely fall and rise up again. This sucks. And BTW [by the way] political anything is 
fucking nonsense doesn't matter how much noise you make unless of course you have 
money. This country is a corrupt piece of shit fucked place to live. I know others are worse, 













APPENDIX E: POSITIONALITY STATEMENT 
I became interested and involved with dietary supplements out of necessity. A year into 
my undergraduate program I developed intense, treatment-resistant insomnia that only grew 
worse. Because of this, I witnessed firsthand the ineffectiveness and ineptitude a person may face 
in the healthcare system; doctors would prescribe a couple of first line treatments that didn’t 
work, shrug their shoulders and then hand me off to someone else so that they cycle may repeat. 
By this point I realized I was going to have to do most of the heavy lifting myself and began 
researching every possible aid, both prescription and over the counter. In this search I eventually 
came across kratom. This is what led me to discovering the r/Kratom subreddit. All of those gave 
me a unique insight into the mentality of individuals who attempt to solve their problems on their 
own through accessible products that do not require doctors or insurance. 
Alongside this experience was bearing witness over the course of my life to a government 
that over-policed the behaviors of its common citizens while only begrudgingly doing the bare 
minimum for them in terms of social and economic policy. This was a sharp contrast to the 
degree of leniency and support it provides to the economic elite—the ultra-wealthy and 
monolithic corporations—in terms of criminal penalties, taxation, and financial safety nets. It is 
these two beliefs and experiences that led me to conceptualizing the project in the manner that I 
did. 
 
